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ABSTRACT 
Proton fluxes through plasma membranes are essential for regulating intracellular 
and extracellular pH and mediating co-transport of metabolites and ions. Although 
conventional electrical measurements are highly sensitive and precise for proton current 
detection, they provide limited specificity and spatial information. My thesis focuses on 
developing optical approaches to visualize proton fluxes from ion channels and 
transporters. 
It has been demonstrated that channel-mediated acid extrusion causes proton 
depletion at the inner surface of the plasma membrane. Yet, proton dynamics at the 
extracellular microenvironment are still unclear. In Chapter II, we developed an optical 
approach to directly measure pH change in this nanodomain by covalently attaching 
small-molecule, fluorescent proton sensors to the cell’s glycocalyx using glyco-
engineering and copper free ‘click’ chemistry. The extracellularly facing sensors enable 
real-time detection of proton accumulation and depletion at the plasma membrane, 
providing an indirect readout of channel and transporter activity that correlated with 
whole-cell proton current. Moreover, the proton wavefront emanating from one cell was 
readily visible as it crossed over nearby cells. 
The transport of monocarboxylates, such as lactate and pyruvate is critical for 
energy metabolism and is mainly mediated by proton-coupled monocarboxylate 
transporters (MCT1-MCT4). Although pH electrodes and intracellular fluorescent pH 
sensors have been widely used for measuring the transport of proton-coupled MCTs, they 
are unable to monitor the subcellular activities and may underestimate the transport rate 
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due to cell’s volume and intracellular buffering. In Chapter III, we used the Chapter II 
approach to visualize proton-coupled transport by MCT1-transfected HEK293T cells and 
observed proton depletion followed by a recovery upon extracellular perfusion of L-
lactate or pyruvate. In addition, we identified a putative MCT, CG11665/Hrm that is 
essential for autophagy during cell death in Drosophila. The results demonstrate that Hrm 
is a bona fide proton-coupled monocarboxylate transporter that transports pyruvate faster 
than lactate. 
Although the approach developed in Chapter II enables visualization of proton 
fluxes from ion channels and transporters, it’s not applicable in some cell types which 
cannot incorporate unnatural sialic acid precursors into their glycocalyx, such as INS-1 
cells and cardiomyocytes. To address this, in Chapter IV we developed a pH-sensitive, 
fluorescent WGA conjugate, WGA-pHRho that binds to endogenous glycocalyx. 
Compared to the results in Chapter II and III, cell surface-attached WGA-pHRho has 
similar fluorescent signals in response to proton fluxes from proton channel Hv1, omega 
mutant Shaker-IR R362H and MCT1. With WGA-pHRho, we were able to label the 
plasma membrane of INS-cells and cardiomyocytes and visualized the transport activity 
of MCT1 in these cells.  
Taken together, these findings provide news insights into proton dynamics at the 
extracellular environment and provide new optical tools to visualize proton fluxes from 
ion channels and transporters. Moreover, the modularity of the approaches makes them 
adaptable to study any transport events at the plasma membrane in cells, tissues, and 
organisms. 
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PREFACE 
The experimental work in Chapter II has been published in a peer-reviewed 
journal. Reference to publication that represent the work contained within this chapter: 
 
L. Zhang, K. Bellve, K. Fogarty, W.R. Kobertz, Fluorescent visualization of cellular 
proton fluxes, Cell Chemical Biology 23, (2016) 1449-1457. 
 
The experimental work in Chapter III and IV has been written up as manuscripts 
for publication at the time of this thesis publication. I synthesized azido-sugar, pH-DIBO 
and pHRho-COOH, and cloned all genes into pcDNA3.1 and performed the perfusion 
experiments in HEK293T and INS-1 cells. Dr. Mei Zhang made all WGA conjugates 
used in Chapter IV, performed patch clamp in CHO cells and perfusion experiments in 
cardiomyocytes. She is also credited in isolation and culture of cardiomyocytes. Genes of 
human GFP-Hv1, ClC-5, Shaker-IR omega mutants and MCT1 were gifts from David 
Clapham (Harvard Medical School), Michael Pusch (Istituto di Biofisica), Baron Chanda 
(University of Wisconsin- Madison) and Dr. Sebastián Brauchi (Universidad Austral de 
Chile), respectively. Panagiotis D. Velentzas (Baehrecke Lab, UMassMed) provided the 
gene of Hrm.  
CHAPTER I. INTRODUCTION 
Rapid proton transport through voltage-gated proton channels (Hv1) and proton-
coupled membrane transporters is essential for maintaining intracellular pH, driving 
substrate transport, regulating gastric and airway mucosal acidity and providing 
electrogenic shunts for phagocytic and endocytic processes. Gain-of-function mutations 
that create unregulated proton pores in voltage-gated cation channels have been 
implicated in myotonias, periodic paralysis, and some forms of long QT syndrome. Given 
their varied physiological and pathophysiological roles, proton transport proteins are 
important therapeutic targets for treating human diseases. However, conventional 
electrical measurements do not directly reveal the identity of the transported ion(s) or the 
subcellular location(s) of activity, nor do they report on non-electrogenic transport events. 
Thus, an approach for spatiotemporally detecting proton fluxes at the plasma membrane 
remains an important research methodology to develop. 
Voltage-gated Proton Channels (Hv1) 
The existence of voltage-gated proton channels was first suggested in 
bioluminescent dinoflagellates in 1972 by Margaret Fogel and J.W. Hastings [1]. Ten 
years later, voltage-activated proton currents were first recorded in snail neurons [2] and 
subsequently observed in a number of different cells (e.g. airway epithelium [3], sperm [4] 
and microglia [5]). It was not until 2006 that a voltage-gated proton channel (Hv1) was 
identified by two groups independently [6,7].  
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Hv1 is distributed in diverse species and has wide physiological and 
pathophysiological roles [8]. For example, protons extruded by Hv1 in phagocytes 
facilitate the production of reactive oxygen species (ROS) to kill pathogens [9–15]. In 
Hv1 KO mice, ROS production in neutrophils is reduced by 65-75% [12], 30% [11] or 74% 
[13], in B lymphocytes by 65% [14] and in microglia by 50% [15]. Hv1 also plays a key 
role in the capacitation and motility of human sperm [8]. It is proposed that a high 
concentration of ambient Zn2+ in seminal fluid prevents Hv1 from opening [16], and that 
low intracellular pH  keeps sperm quiescent. After entering the female, the environment 
becomes more alkaline with a lower Zn2+ concentration and sperm extrudes protons 
through Hv1, leading to stimulation of the metabolic activity and motility [17]. 
Nevertheless, Hv1 is also detrimental in some respects. Recent studies raise concerns 
about Hv1 involvement in breast cancer metastasis. Wang et al. found high levels of 
hHv1 mRNA in the metastatic cell line MB-231 and low levels in a weakly metastatic 
line MCG7 [18]. Further analysis performed by the same group suggests that there is a 
significant correlation between hHv1 expression and tumor size, tumor classification and 
clinical stage [19]. Moreover, Hv1 in microglia is required for NOX-dependent ROS 
production that induces neuronal cell death after ischemic stroke [15]. 
Canonical voltage-gated ion channels, such as Nav, Kv, and Cav channels are 
composed of four subunits each of which has six transmembrane segments (S1-S6), 
including a voltage-sensing-domain (VSD, S1-S4) and a pore domain (PD, S5-S6) 
(Figure I-1A) [20]. In contrast, Hv1 has a VSD, but lacks a PD (Figure I-1B) [6,7]. It 
forms a dimer on the biological membranes, and each monomer has its own proton 
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permeation pathway [21–23] and gates cooperatively [24]. The fourth transmembrane 
segment (S4) has three positively charged residues (Arg) at every third position. Upon 
depolarization, S4 moves upward relative to other helices [24], as it does in other voltage-
gated ion channels, opening the proton pathway. Asp112 in S1 is highly conserved and is 
critical for the selectivity filter of Hv1. Replacing Asp112 with a neutral amino acid 
causes a loss of proton specificity and makes Hv1 anion-selective or non-conductive [25]. 
Phe150 in S2 is located close to the proton permeation pathway and is required for the 
intracellular binding of a guanidine compound, 2-guanidinobenzimidazole (2GBI) that 
acts as an open-channel blocker [26]. Zinc ion (Zn2+) is the most potent channel inhibitor 
for Hv1 (micromolar level) [27]. The inhibition is thought to be the result of four residues 
(His136, His189, Glu115 and Asp119) that may contribute to the Zn2+ ion coordination in 
Hv1 according to the crystal structure of Hv1 in the resting state obtained in 2014 [28] 
(Figure I-1C). 
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Figure I-1. Topology schematics and representative currents of voltage-gated K+ 
channels and Hv1 channels. (A) In voltage-gated K+ channels, the first four 
transmembrane domains (S1-S4, colored green) comprise the voltage sensing domain 
(VSD); four Arg residues are on S4 (denoted as R1 to R4 from extracellular to 
cytoplasmic side); the fifth and sixth transmembrane domains (S5-S6, colored orange) 
form the pore domain (PD); representative currents are recorded from Xenopus oocytes 
expressing Shaker-IR channels [29] and are elicited from a holding potential of – 90 mV 
by activating pulses of – 60 to 50 mV with intervals of 10 mV (scale bars: 20 ms, 1 µA). 
(B) Hv1 channels only have S1-S4 and three Arg residues on S4 (R1 to R3); 
representative currents are recorded from HEK293 cells expressing hHv1 channels [6] 
and are elicited from a holding potential of – 40 mV by activating pulses of – 60 to 120 
mV with intervals of 20 mV (scale bar: 200 ms, 1 nA). (C) Zn2+ binding site in Hv1 in 
resting state. Zn2+ is drawn in blue mesh and views from different directions are shown in 
(a) and (b) [28]. 
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One of the most surprising characteristics of Hv1 is its incredibly high selectivity 
for protons. The estimate of the selectivity factor for protons over other cations is more 
than 107. Therefore, it is proposed that protons are conducted by a hydrogen bond chain 
in Hv1 using a Grotthuss mechanism whereby protons diffuses through the hydrogen 
bond network of water molecules and/or other hydron-bonded residues [30]. Interestingly, 
mutations in the VSD of other voltage-gated ion channels can also induce a leaky proton 
current called omega current through the VSD [31–33], implying that they might have a 
similar proton conduction mechanism to Hv1. The details of this leaky proton current will 
be discussed later in this chapter.  
In addition, Hv1 is voltage-gated, meaning that it opens when the membrane 
potential is depolarized. The activating current is curved in a sigmoid manner and 
deactivating current is exponential (Figure I-1A) [34]. However, at least in mammals, 
Hv1 gating is much slower (> 5 seconds in phagocytes) than Kv and Nav channels, which 
open within a millisecond (Figure I-1B) [34,35]. Consequently, it is suggested that the 
two monomers must undergo conformational changes upon depolarization before either 
one can conduct protons [24].  Several studies have demonstrated that Hv1 functions as a 
monomer and exhibits a 5-7 times faster gating when the C-terminus is truncated 
[21,36,37].  
Hv1 is also sensitive to the intracellular (pHi) and extracellular pH (pHo). 
Increasing pHo or decreasing pHi shifts the G-V curve negatively by 40 mV per unit 
change in pH [38]. This sensitivity makes it difficult to determine the maximal proton 
current experimentally, because proton efflux can cause a local proton depletion in the 
5
cytoplasmic side and thus increase local pHi, even with 100-200 mM buffer in the pipette 
solution [3,38]. Direct evidence for this local proton depletion was provided by De-la-
Rosa et al. who labeled Hv1 with a genetically-encoded pH sensor at the cytoplasmic 
domain [39]. Proton dynamics at the extracellular space upon Hv1 opening are still 
unclear. 
Buffer capacity on both sides (Bo and Bi) also affects Hv1 activity. At a constant 
pHi of 5.5, increasing Bi from 5 to 120 mM increases the maximum current density from 
8.7 to 27.3 pA/pF [3]. A follow up study by the same group shows that decreasing Bo 
from 100 to 1 mM does not alter the G-V curve but reduces the current density by 10-30% 
[40]. In contrast, the same decrease in Bi alters the current density more distinctly while 
subtly changing the kinetics [40]. All these experimental results suggest that lower Bo 
causes more proton accumulation at the extracellular side and thus reduces the proton 
gradient, leading to a smaller proton current. It is also supported by a mathematical model 
that estimates changes in pHo at different Bo [41]. However, to date, there is no direct 
experimental evidence to support this hypothesis. 
Omega Currents 
Canonical voltage-gated cation channels (Na+, K+ and Ca2+ channels) are widely 
distributed and are crucial for the propagation of electrical signals in neurons. Their 
VSDs are formed by the first four transmembrane segments and share a similar structure 
to Hv1 but have more than four positively charged residues (Arg or Lys) in S4 (denoted 
as R1, R2, R3, R4…from extracellular to cytoplasmic side). The PDs constituted by S5-6 
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form central pores (also known as alpha pores), allowing ions to travel through when 
channels open (Figure I-1A). Unlike Hv1, the outward movement of S4 in these channels 
does not open a proton permeable pathway in VSD, but opens the central pore via the 
force of conformation changes [20,42,43]. 
Mutations of the charged residues in S4 in these channels may cause a leaky ion 
flux through the VSDs called omega current. It was first described in a voltage-gated 
potassium channel, Shaker. Replacing the first arginine R1(362) with histidine (R1H) in 
Shaker generates an inward proton current upon hyperpolarization (Figure I-2A) [32]. 
This omega proton current is voltage dependent and becomes larger when the proton 
reversal potential (EH) is more positive. It can be blocked by addition of nickel, which 
binds to histidine, but is not affected by the alpha pore blocker agitoxin II. These data 
indicate that the omega current travels through the VSD with the involvement of the 
replaced histidine. Additionally, substitution of R1 by other residues with shorter side 
chains (e.g. cysteine, serine and alanine) generates non-proton omega currents carried by 
alkali metal cations [44], such as Cs+, K+ and Li+. In comparison with R1H, Shaker 
mutant R4(371)H produces an outward proton current upon depolarization (Figure I-2C) 
[45]. Meanwhile, R2(365)H and R3(368)H mutants behave as voltage-gated proton 
transporters (Figure I-2B) [31]. 
Other voltage-gated cation channels also have similar gain of function mutations 
which can result in channelopathies [46]. For instance, hypokalemic periodic paralysis 
(HypoPP) is a heritable muscle disorder that has been linked to mutations located in the 
S4 arginine residues in skeletal muscle channels Nav1.4 and Cav1.1. Similar with Shaker 
7
R1H, both Nav1.4 R1(669)H and Cav1.1 R1(528)H mutants produce inward omega 
proton currents in the resting state [33,47,48]. Although the omega current is only 1% of 
the alpha current, this sustained proton leak may contribute to the abnormally depolarized 
muscle membrane and the failure of muscle action potential firing in HypoPP. Omega 
currents also have been implicated in other channelopathies, such as benign familial 
neonatal seizures (BFNS) [49], long QT syndrome (LQT) [50], and familial hemiplegic 
migraine (FHM) [51], among others. 
The production of omega currents is explained by a voltage-dependent salt-bridge 
switching mechanism [52]. In the resting state, the first S4 arginine (R1) with an acidic 
residue (S2 E283 in KvAP) forms a salt-bridge that functions as a gate segregating the 
extracellular fluid from the cytoplasmic fluid (Figure I-2A, top). Shortening or 
neutralizing the arginine residue breaks the gate and opens the omega current pathway 
(Figure I-2A, middle). With S4 moving outwardly upon depolarization, one of the other 
deeper arginine residues occupies the R1 position and forms a new salt-bridge (Figure I-
2B and C, top). Therefore, mutation in R2, R3 or R4 only opens the omega pore at certain 
membrane potentials. In some cases, mutations on two adjacent arginine residues are 
required to generate omega currents suggesting that the size and shape of the omega gate 
is variable in different voltage-gated ion channels [53,54]. 
To study omega mutations, the central pore must be blocked as omega currents 
are small with respect to the alpha current. However, blocking the central pore either with 
chemical blockers like tetrodotoxin [50] or using a non-conducting mutation (W434F in 
Shaker) [32] does not completely inhibit the alpha current. Moreover, both methods may 
8
change the conformation of VSD within which the omega current pathway is located. 
Hence, a new technique is desirable to detect omega currents without blocking the central 
pore. 
  
9
S1-S3 -+ R1
R2
R3
R4
+++
S1-S3 -+
R1
R2
R3
R4
+++
S1-S3 -
+ R1
R2
R3
R4
+++
S1-S3 - H1
R2
R3
R4
+++
S1-S3 -+
R1
H2
R3
R4
++
S1-S3 -
+ R1
R2
R3
H4
++
X X
X
Depo
Hyper
Depo
Hyper
H+
H+
R1H mutation R2H or R3H mutation R4H mutation
I H
(µ
A)
0
-1 
-2
-150 -100 -50 0Pulse potential
(mV)
0.6
0.3
0.0
-0.3
-100 -50 0 50
0
-0.2
-0.4
-150 -100 -50 0 50
EH
-138 
-72 
23 
(mV)
EH (mV)
-121
-69
-23
35
78
EH (mV)
-98
-6
34.5Omega 
proton currents
Kv channel gating
Omega mutation
A B C
H+
Figure I-2. The ‘salt-bridge switching’ model of S4 movement. Plus signs (red) 
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Proton-coupled Transporters 
Protons represent one major driving force for secondary active transporters. The 
electrochemical gradient of protons provides energy to transport another ion or 
metabolite against its electrochemical gradient. A few examples of proton-coupled 
transporters are shown in Figure I-3A. In the following section, I will focus on the 
transporters ClC-5 and MCT1, which are two classical exemplars of proton-coupled 
antiporters and symporter, respectively. 
ClC-5, a Voltage-gated H+/Cl- Antiporter 
Cl- is the most abundant anion in both extra- and intra-cellular fluid and is 
essential for many critical physiological functions such as neuronal and muscle 
excitability, osmotic homeostasis and endosome-lysosome acidification [55]. ClC 
proteins represent a large family of Cl- transporters in cells. Since the first ClC protein, 
ClC-0 was discovered [56] and was fully characterized [57] from Torpedo marmorata, 
the roles of Cl- flux have attracted research interest resulting in the identification of nine 
mammalian ClC proteins (ClC-1 to ClC-7, ClC-Ka and ClC-Kb). These ClC proteins are 
expressed as dimers with each monomer exhibiting independent ion conductance. 
Although they have similar structures, four of them function as Cl- channels at the plasma 
membrane (ClC-1, -2, -Ka, -Kb), and the other five are organelle H+/Cl- antiporters (ClC-
3 to ClC-7) [55]. 
ClC-5 is highly localized in endosomes of renal proximal tubule cells [58]. It was 
first identified as a protein defective in Dent’s disease [59], a chronic kidney disorder that 
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has dysfunction of tubular reabsorption for low molecular weight proteins and Ca2+. Mice 
lacking ClC-5 exhibits several characteristic symptoms of Dent’s disease, such as loss of 
low molecular weight proteins and defective endocytosis [60]. In addition, ClC-5 is co-
localized with V-type H+-ATPase in endosomal membranes which actively pumps H+ 
into endosomes [61]. Therefore, it was thought that ClC-5 was a Cl- channel, an electrical 
shunt for maintaining ATP-induced acidification in endosomes. This supposition was 
accepted until 2005 when ClC-5 was determined to be a H+/Cl- antiporter instead of a Cl- 
channel, as the proton flux from this antiporter acts in opposition to the activity of the H+-
ATPase [62,63]. Later on, it was found that the point mutation E211A blocks the proton 
pore and converts ClC-5 into a pure Cl- conductor [64]. Renal endosomal acidification is 
normal in mice carrying this mutation but is reduced in ClC-5 KO mice. Surprisingly, 
these two types of mice both show impaired endocytosis. All these results indicate that 
H+/Cl- exchange is crucial for endocytosis. However, the exact role of ClC-5 is still 
poorly understood.  
ClC-5 is the most well-studied human ClC transporter largely due to the fact that 
it can be robustly expressed at the plasma membrane in heterologous expression systems, 
like HEK293 cells and Xenopus oocytes [58,65]. According to electrophysiological 
studies, ClC-5 is voltage dependent and is active only when the membrane potential is 
more than 0 mV [62,66]. It only conducts outward currents, corresponding to Cl- influx 
and H+ efflux [66]. In general, changes in intra- and extra-cellular pH and Cl- ([Cl-]i and 
[Cl-]o) have a small effect on current density and activation of ClC-5. Decreasing pHo 
from 7.4 to 5.4 reduces the current density and shifts activation to more positive 
12
potentials. Changes in intracellular pH have a similar effect on voltage-activation but 
have little effect on current density. Meanwhile, changing [Cl-]o causes a small change in 
current density, but does not affect voltage-activation. Increasing [Cl-]i from 10 to 140 
mM shifts both G-V and I-V curves to more positive potentials [66]. Despite the shifts in 
the G-V and I-V curves, no inward current is observed. Such an extreme outward 
rectification makes it infeasible to determine ClC-5 stoichiometry accurately using 
electrical measurements. Consequently, an optical method has been developed to 
specifically detect changes in the extracellular proton concentration close to the surface 
of Xenopus oocytes by means of a pH sensitive dye, BCECF and demonstrated a 2 Cl-/1 
H+ stoichiometry for ClC-5 [67]. Unfortunately, this method is not adaptable in 
mammalian cells as the detectable surface area is negligible. 
A hypothetical model for the mechanism of Cl- and H+ transport is proposed 
based on mutagenesis studies and the crystal structure of bacterial ClC-ec1 that has a 
similar molecular architecture to mammalian ClC proteins [68,69]. There are three anion 
binding sites: the external (Sext), central (Scen) and internal (Sin) binding sites in the ion 
permeation pathway (Figure I-3B). A negatively charged residue, referred to as the 
“gating glutamate”, Egat (E211 in ClC-5) is a central element for Cl- and H+ transport. 
When Egat is in an unprotonated form, its side chain swings from extracellular 
environment driving 2 chloride ions to the intracellular solution (Figure I-3B, b and c). 
Subsequently, Egat accepts a proton from the intracellular proton pathway followed by a 
conformation change that delivers the proton to the extracellular solution (Figure I-3B, d 
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and e). However, the exact mechanism of this transport has not been fully experimentally 
verified yet.  
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Proton-coupled Monocarboxylic Acid Transporters (MCTs) 
Monocarboxylates, such as pyruvate, lactate and ketone bodies are often products 
of carbohydrate, fat and amino acid metabolism and must be released across the plasma 
membrane rapidly for prevention from excessive acidosis. In some tissues (brain, heart, 
red skeletal muscle), they are also utilized as respiratory fuels and need to be taken up by 
cells [70–75]. Both types of transport are mainly mediated by proton-coupled 
monocarboxylic acid transporters (MCTs), including MCT1-MCT4 encoded by a SLC16 
family of genes in mammals.  
According to theoretical predictions and biochemical assays, these four MCTs 
have a similar topology comprised of 12 transmembrane (TM) domains with cytoplasmic 
N- and C- termini, one large intracellular loop between TM6 and TM7, and two highly 
conserved sequences in TM1 and TM5 [75]. Localization of MCTs to the plasma 
membrane requires association with an ancillary protein: basigin (CD147) or embigin 
(gp70) which has a single transmembrane domain, an immunoglobulin-like extracellular 
segment and a short cytoplasmic tail. It has been shown that MCT1, 3 and 4 associate 
with basigin [76,77], while MCT2 associates with embigin [78]. 
The structure of MCT1 derived from molecular modeling [73] and mutagenesis 
studies [79–82] reveals that K38 provides a binding site for the monocarboxylate anion, 
such as lactate after protonation (Figure I-3C, b and c).  This binding event induces a 
conformational change which drives a translocation of lactic acid to the D302/R306 site 
(Figure I-3C, d). Meanwhile, K38 is deprotonated and the conformation relaxes, resulting 
in D302/R306 exposure to the intracellular environment and subsequent lactic acid 
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release (Figure I-3C, e) [79,80,82]. F360, which closes to D302/R306, is critical for the 
substrate selectivity. An F360C mutation enables MCT1 to transport mevalonate, a larger 
monocarboxylate [83].  
MCT1 was first identified in Chinese hamster ovary (CHO) cells [83] and is the 
most well-studied MCT. Despite its ubiquitous tissue distribution, MCT1 exists in 
specific locations of cell membranes. For example, in isolated rat cardiomyocytes, MCT1 
is more expressed in intercalated disc and T-tubule regions [84]. There is a broad range of 
substrates for MCT1, such as lactate, pyruvate, hydroxybutyrate, acetoacetate, acetate 
and butyrate. Although acetate and butyrate can be transported by MCT1, they mainly go 
across the plasma membrane by passive diffusion in undissociated forms because of their 
high pKa values [73]. Lactate is the most important substrate for MCT1. Interestingly, 
transport of lactate via MCT1 is stereoselective. In oocytes, the Km for D-lactate (> 60 
mM) is ~ 17-fold higher than that for L-lactate (3.5 mM). Meanwhile, the transport of L-
lactate is 2.7 times faster than that of D-lactate at 10 mM. MCT1 shows a higher affinity 
for pyruvate (Km = 1 mM), but the transport rate of pyruvate is only about half of that of 
L-lactate at 10 mM [85].  
Several MCT inhibitors have been identified, such as 2-Cyano-4-
hydroxycinnamate (CHC) and its analogs, phloretin, flavonois, stilbene disulphonates and 
AR-C155858. In particular, CHC has been widely used for the discovery and 
characterization of MCTs [85–90]. The Ki value of CHC is 166 M for MCT1 in mouse 
breast tumor cells, which is higher than that of phloretin (5.1 M) [91]. AR-C155858 
developed by AstraZeneca recently exhibits high specificity and affinity for MCT1 but no 
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activity for MCT4 [92]. It also can inhibit MCT2 only when it is associated with basigin 
rather than embigin. The inhibition is time dependent and also exists when injected 
intracellularly, suggesting that AR-C155858 probably binds to an intracellular site of 
MCT1. 
Besides MCT1-4, there are ten other transmembrane proteins encoded by the 
SLC16 family of genes in mammals, named MCT5-14. Only MCT11 has been shown to 
be a proton-coupled MCT and most recently has been associated with type 2 diabetes 
[93]. MCT6 is likely to be a proton-coupled transporter, as it has been reported to 
facilitate the proton-linked transport of bumetanide but its natural substrate remains 
unknown [94]. The other identified MCTs are not proton-coupled and are either a thyroid 
hormone transporter (MCT8) [95] or a carnitine transporter (MCT9) [96] or an aromatic 
amino acid transporter (MCT10) [97]. MCT7 has been implicated in the hepatocyte 
secretion of ketone bodies during fasting [98]. Thus far, the substrates and functions of 
MCT12-14 are still unknown.  
MCTs also exist in other organisms, such as Drosophila melanogaster, which is a 
useful genetic model organism for studying autophagy. There are 14 genes in Drosophila 
with variable homology to the members of the mammalian SLC16 family. However, only 
two have been functionally identified to transport monocarboxylates. Silnoon/dMCT1 
mediates transport of butyrate and lactate and is crucial for triggering LKB1 dependent 
apoptosis [99]. Chaski that is enriched in glial cells has been identified more recently as a 
lactate/pyruvate transporter [100]. Baehrecke’s group in UMass Medical School also 
discovered a gene, CG11665/hrm that shows significant sequence similarity to SLC16 
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genes and is required for both autophagy during steroid-triggered salivary gland cell 
death and TNF-induced non-apoptotic eye cell death (unpublished). However, it is still 
unknown whether it functions as MCTs and what its substrates are.  
Unlike ClC-5, transport of proton-coupled MCTs is non-electrogenic, making it 
challenging to measure MCTs activities. Radiolabeled substrates have been commonly 
used for activity measurements due to their high specificity and sensitivity [83,86,101–
104]. The transport rate is measured by determination of intracellular labeled substrates 
after rapid termination. However, the diffusion and metabolism of substrates during the 
procedures may generate substantial errors. Genetically-encoded pyruvate and lactate 
fluorescent sensors have been developed for intracellular substrate measurements 
[93,105,106]. They enable a real-time measurement of transport, but their KD values limit 
the detectable concentration range of substrates. Because of the associated proton 
transport, the activity of MCTs can also be measured in real time by monitoring pHo or 
pHi using pHo or pHi electrodes [79,85,107,108] or pHi sensitive dyes, such as BCECF-
AM [70,89,91,109–111].  Although electrodes and dyes enable determination of pHi and 
pHo, the spatiotemporal visualization of MCTs activities at the plasma membrane has not 
been tenable with existing tools. 
Fluorescent pH Sensors 
Proton fluxes through ion channels and transporters are not only essential for 
regulation of intracellular pH, but also are involved in many cellular activities, such as 
signaling and motility [4,112–114]. Patch clamp is a common technique in 
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electrophysiology for studying ionic currents. It can detect proton currents from e.g. 
proton channels (Hv1) but is unable to directly reveal the identity of the transported ion(s) 
or the subcellular location(s) of activity. In contrast, proton-sensitive microelectrodes 
provide a direct readout of the extracellular pH, but only at a single macroscopic location 
abutting the cell. Despite their high sensitivity and precision, both techniques are time-
consuming and challenging, and provide negligible spatial information. Given these 
constraints from electrical recordings, various fluorescent pH sensors have been 
developed and employed to visualize changes in intra- and extra-cellular pH. 
Small-molecule Fluorescent pH Sensors 
At present, many pH-sensitive fluorescent dyes have been developed and can be 
classified into two groups based on their sensing mechanisms. Fluorescent pH sensors, 
such as fluorescein, BCECF, SNARF and HPTS belong to the first group having 
fluorescence controlled by the ionization of phenolic hydroxyl groups (Figure I-4A). In 
particular, 2’, 7’-Bis-(2-carboxyethyl)-5-(and-6-)carboxyfluorescein (BCECF) developed 
by Roger Tsien in 1982 is the most widely used pH sensor [115]. Because it is a 
fluorescein-based dye, it forms a non-fluorescent lactone upon protonation. As pH 
increases, it becomes a fluorescent phenolate anion, and the wavelengths of the maximum 
absorption (max abs) and emission (max em) are 503 and 525 nm, respectively. The pKa of 
BCECF is 7.0 which makes it suitable for sensing intracellular pH (6.8-7.4). Ratiometric 
pH measurements can be done with BCECF by measuring the ratio of emission intensity 
excited at ~ 490 nm versus the emission intensity excited at its isosbestic point (~ 440 
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nm). The commercially available acetoxymethyl ester of BCECF enters cells more easily 
and is retained inside cells after deacetylation by esterase. This ester version (BCECF-
AM) has been used for monitoring pHi in real time when proton fluxes through 
membrane proteins, such as proton pumps [116], Hv1 channels [19], MCTs [73] and 
sodium-proton exchangers (NHEs) [117]. 
In the second group, the fluorescent dyes have an amine group that serves as a 
proton-sensing moiety and responds to pH changes under a Photoinduced Electron 
Transfer (PET) signaling mechanism (Figure I-4B). Because protonation of the amine 
group blocks PET-quenching, these pH sensors become more fluorescent as pH decreases. 
For example, pHrodo red and pHrodo green are rhodamine-based pH sensors introduced 
by Life Technologies [118]. With a pKa of ~ 6.5, both sensors have dim fluorescence 
above pH 8 and become more fluorescent in an acidic environment. Moreover, they do 
not photobleach significantly after 12 min of imaging and have been used for determining 
the engulfment of apoptotic cells by macrophages [119]. Recently, Aigner et al. have 
developed another rhodamine-based pH sensor that can be synthesized in only three steps 
[120]. It has a pH1/2 of 6.9 and absorption/fluorescence maximum at 561 nm and 591 nm, 
respectively. Because it has two amine groups, protonation of both amines is required to 
block PET quenching completely (Figure I-4B). An extra carboxyl group in this sensor 
enables conjugation with other biomolecules of interest.   
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Genetically Encoded Fluorescent pH Sensors 
The green fluorescent protein (GFP) and its variants have become an essential 
toolbox in biological research over the past two decades.  Because GFPs are genetically 
encodable, they have extremely high specificity and have been widely used as reporters 
for gene expression, localization markers and biochemical monitors. All GFPs are pH 
sensitive, allowing them to serve in pH sensing applications. The first two GFP-based pH 
sensors, named ‘ratiometric’ and ‘ecliptic’ pHluorins are developed by Rothman group 
using structure-directed combinatorial mutagenesis [121]. Like native GFP, both 
pHluorins have dual excitation peaks at 395nm and 475nm. Upon acidification, the 
absorbance of ecliptic pHluorin decreases at both excitation peaks; ratiometric pHluorin, 
by contrast, exhibits a decrease in the excitation at 395 nm and an increase at 475 nm. 
Targeting ecliptic pHluorin to a vesicle membrane protein enables monitoring of vesicle 
exocytosis and recycling in real time. Although various GFP-based pH sensors have been 
introduced since then, the small range of fluorescence wavelengths (from 509 to 598 nm) 
limits their applications. 
Monitoring Extracellular pH 
Intracellular pH measurements are used for proton flux quantification. However, 
these measurements are not able to detect the kinetics of proton fluxes accurately, 
because the cell volume and intracellular buffering slow down the pHi change. 
Furthermore, monitoring global pHi changes does not directly reveal the subcellular 
location(s) of proton transport activities. Sensing extracellular pH, therefore, is a more 
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appropriate approach for detecting proton fluxes. Based on either genetically encoded 
fluorescent sensors or small-molecule fluorescent sensors, several strategies can be 
applied for attaching sensors to the plasma membrane. 
Expression of Genetically Encoded Fluorescent Sensors at Extracellular Surface 
One strategy is to fuse a GFP-based fluorescent sensor to an extracellular domain 
of a membrane protein (Figure I-5a). For example, Du et al. fused SE-pHluorin to 
syndecan 2, a postsynaptic membrane protein, and found a transient acidification 
followed by a slower alkalization at the extracellular space of spines and the neighboring 
dendrites after stimulating cortical inputs [112]. Because this approach is accomplished 
by gene editing, it has high specificity and enables long-term imaging in vitro and in vivo. 
Limitations of this approach include possible poor trafficking and low signal to noise due 
to low expression after fusion. 
Conjugation of Small-Molecules Fluorescent Sensors to The Extracellular Surface 
Small-molecule fluorescent sensors can be modified through synthesis and can be 
conjugated to either membrane proteins, lipids, or carbohydrates at the extracellular 
surface by using semisynthetic approaches. For example, to image exocytosis and 
endocytosis, Martineau et al. attached pH-sensitive dyes to either expressed self-labeling 
tags such as SNAP-tag on the membrane proteins of synapse vesicles, or to antibodies 
that recognize native vesicular proteins [122]. Similar strategies can also be applied at the 
plasma membrane (Figure I-5c and d).  
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Small-molecule dyes can be anchored to lipids directly (Figure I-5b). Stock et al. 
labeled extracellular lipid head groups with DHPE-fluorescein for studying pH 
nanoenvironment at the extracellular surface of single melanoma cells [123]. To make a 
comparison, they used a wheat germ agglutinin (WGA)-fluorescein conjugate for 
glycocalyx labeling and found that pHo in melanoma cells is higher right at the plasma 
membrane than in the glycocalyx (Figure I-5f). Ke et al. developed a lipid-DNA scaffold 
consisting of a hydrophobic diacyllipid tail and a hydrophilic DNA strand [124]. For 
extracellular pH sensing, this scaffold is further modified with two fluorescent dyes: one 
is pH sensitive and the other is pH insensitive as internal reference.  
Besides WGA conjugates, a glycocalyx engineering methodology has been 
applied for covalently binding small-molecule dyes to the glycocalyx (Figure I-5e). In 
this method, cells are incubated with synthetic monosaccharides having similar structures 
to natural precursors but bearing unnatural functional groups, such as azido-, alkyne-, 
ketone-, and thiol- [125]. These unnatural sugars enter the cell and are utilized as the 
natural precursors for the biosynthesis of cell surface glycans. The resulting glycans carry 
the functional groups that can covalently binding with small-molecule dyes. Bertozzi’s 
group, for instance, has developed tetraacetylated N-Azidoacetyl-D-Mannosamine 
(Ac4ManNAz) to incorporate azido- groups into the cell’s glycocalyx which can be 
subsequently labeled with fluorescent dyes via bioorthogonal reactions, such as copper-
free ‘click’ chemistry for imaging glycans [126]. 
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Labeling at the cell surface...
tag
WGA
pHluorin
(a) (b) (c) (d) (e) (f)
Figure I-5. Strategies for cell-surface labeling with fluorescent pH sensors. 
Genetically-encoded pH sensors can be fused to a membrane protein (a). Small-molecule 
pH sensors can be conjugated to artificial lipids (colored pink) (b) or bind to a membrane 
protein with SNAP-, CLIP- or Halo-tag (c) or be conjugated to an antibody for a 
membrane protein (d) or covalently bind to an unnatural functional group (colored blue) 
after glycocalyx engineering (e) or be conjugated to WGA that binds to terminal sugar 
residues. 
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Sensing the extracellular pH changes via fluorescent methods can provide 
spatiotemporal information of proton-transport activities to understand their roles under 
physiological and pathophysiological roles. Although several fluorescent methods have 
been developed for monitoring pH changes at various location in and around a cell, the 
real-time and spatiotemporal visualization of proton fluxes through proton channels or 
proton-coupled transporters has not yet been reported.  
Outline of Thesis 
In my thesis work, I focus on developing optical approaches for visualizing 
cellular proton fluxes through ion channels and transporters. 
Chapter II illustrates the development of an optical approach by means of 
glycocalyx engineering and copper-free ‘click’ chemistry. The dense coating of 
extracellular facing pH sensors provides real-time detection of proton accumulation and 
depletion from proton channel Hv1, H+/Cl- antiporter ClC-5 and omega mutants Shaker-
IR R362H and R371H. Moreover, the proton wavefront emanating from one cell is 
clearly visible when it envelopes neighboring cells. 
Chapter III describes the utilization of the approach developed in Chapter II for 
monitoring non-electrogenic transport of proton-coupled MCTs. Compared to 
intracellular pH measurement, our approach shows proton depletion followed by a 
recovery at the cell surface upon extracellular perfusion of L-lactate or pyruvate in 
HEK293T cells expressing MCT1. Furthermore, by using this approach, we functionally 
identified a putative MCT, Hrm that is involved in autophagy in Drosophila.  
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Because the Chapter II approach is not applicable in all cell types, Chapter IV 
describes the development of another approach using a pH sensitive, fluorescent WGA 
conjugate, WGA-pHRho to measure the extracellular pH. Compared to the Chapter II 
approach, WGA-pHRho has a similar fluorescent response to proton fluxes resulting 
from proton channel Hv1 and omega mutant Shaker-IR R362H. By using WGA-pHRho, 
we monitored proton-coupled MCT1 activity in MCT1-expressing INS-1 cells and 
isolated rat cardiomyocytes that cannot use unnatural sialic acid into their glycocalyx. 
The development of these two optical approaches provides new tools for further 
understanding functions of cellular proton fluxes and functional identification of proton-
coupled transporters. 
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CHAPTER II. A BIOORTHOGONAL CHEMISTRY APPROACH FOR 
VISUALIZATION OF PROTON FLUXES AT THE PLASMA MEMBRANE 
Summary 
Cells use plasma membrane proton fluxes to maintain cytoplasmic and 
extracellular pH and to mediate the co-transport of metabolites and ions. Because proton-
coupled transport often involves movement of multiple substrates, traditional electrical 
measurements provide limited information about proton transport at the cell surface. To 
visualize proton fluxes specifically over the entire landscape of a cell, in Chapter II we 
synthesized a small-molecule fluorescent pH sensor and attached it to the cell surface by 
means of glycocalyx engineering and copper free ‘click’ chemistry. The extracellularly 
facing sensors enable real-time detection of proton accumulation and depletion at the 
plasma membrane, providing an indirect readout of channel and transporter activity that 
correlated with whole-cell proton current. Moreover, the proton wavefront emanating 
from one cell was readily visible as it crossed over nearby cells. Given that any small-
molecule fluorescent sensor can be covalently attached to a cell’s glycocalyx, our 
approach is readily adaptable to visualize most electrogenic and non-electrogenic 
transport events at the plasma membrane. 
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Introduction 
Proton fluxes mediated by voltage-gated proton channels and proton-coupled 
transporters are critical for maintaining intracellular pH [30], driving co-substrate 
transport [127], regulating gastric [128] and airway mucosal acidity [129] and providing 
electrogenic shunts for phagocytic and endocytic processes [130]. In addition, Gain-of-
function mutations that create unregulated proton pores in voltage-gated cation channels 
have been implicated in myotonias, periodic paralysis, and some forms of long QT 
syndrome [46]. Given their varied physiological and pathological roles, proton transport 
proteins are viable therapeutic targets for treating human diseases - the most successful 
target has been the gastric proton pump, where irreversible inhibition of this proton flux 
mitigates gastrointestinal reflux disease [131].  
Electrical recordings have unequivocally established that ion accumulation and 
depletion occur at the plasma membrane during normal and pathophysiological activity. 
However, these electrical measurements do not directly reveal the identity of the 
transported ion(s) or the subcellular location(s) of activity, nor do they report on non-
electrogenic transport events. In contrast, proton-sensitive microelectrodes provide a 
direct readout of the extracellular pH [132,133], but only at a single macroscopic location 
abutting the cell. Because both techniques are time consuming, challenging and provide 
negligible spatial information, various small-molecule and genetically encoded 
fluorescent pH sensors have been developed for visualizing pH changes in the cytoplasm 
and intracellular compartments [121,134–137]. Moreover, extracellular pH has been 
measured by using WGA-fluorescein conjugates [123], lipid-anchored pH sensors 
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[123,124,138] and genetically encoded pH sensors fused with membrane proteins [112]. 
Although these reagents have enabled pH determinations at various locations in and 
around a cell, the real time visualization of voltage-dependent proton fluxes at the plasma 
membrane has not yet been reported.  
Here we used glycocalyx engineering and copper-free ‘click’ chemistry to 
covalently label the cell surface with small-molecule fluorescent pH sensors to visualize 
proton fluxes at the plasma membrane. Using voltage-clamp fluorometry to 
simultaneously control and visualize proton transport, we observed robust fluorescent 
signals that corresponded to cellular proton fluxes in both directions: outward and inward. 
The real-time kinetics of proton accumulation and depletion at the cell surface directly 
correlated to current density and buffer capacity, permitting the fluorescent signal to 
serve as a surrogate of ion channel and membrane transporter activity. The proton 
selectivity and sensitivity of the fluorescent signal enabled the determination of the 
proton current through H+/Cl- antiporter ClC-5 and the visualization of omega proton 
fluxes in the presence of a fully functioning voltage-gated Shaker potassium channel, 
where 6% of the total current was carried by protons. Strikingly, the resultant proton 
wavefront emanating from one cell was readily detected as it enveloped adjacent cells 
that were covalently modified with pH sensors. 
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Results 
Chemistry, Cell Surface Labeling and Characterization 
Compared to targeting or overexpressing a specific membrane protein, we 
hypothesized that a bioorthogonal chemical reaction with the cell’s glycocalyx would 
result in a uniform and dense coating of fluorescent pH sensors at the cell surface to 
enable visualization of extracellular proton fluxes. To covalently modify the cell surface 
with small molecule fluorescent pH sensors, we used metabolic engineering with a 
membrane permeant peracetylated unnatural sugar to install azido groups into the cell’s 
glycocalyx [139,140], which were subsequently modified with pH-DIBO — an azido-
reactive, rhodamine-based pH sensor (Figure II-1A). The photoinduced electron transfer 
(PET) rhodamine pH sensor (pH-DIBO) was synthesized using a modified literature 
procedure [120] where the piperazine groups were Boc-protected to simplify purification 
(Figure II-1B). A pendant amine group was attached to 2 by first reaction with 2-
ethylcarboxymercaptan followed by peptide coupling with 1,2-bis(2-aminoethoxy)ethane. 
Reaction of 2 with the 4-nitrobenyl ester of DIBO, and subsequent removal of the Boc 
groups with TFA yielded pH-DIBO in six steps from 3-(1-piperazinyl)phenol. 
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Figure II-1. Glycocalyx engineering strategy to visualize plasma membrane proton 
fluxes. (A) Cells expressing ion channels or membrane transporters are incubated with an 
azidosugar (azido group in blue) and the cell surface is subsequently labeled with a 
fluorescent pH sensor (pH-DIBO) to detect proton fluxes. The azide-reactive and 
fluorescent pH-sensitive groups in the chemical structure and label are colored blue and 
red, respectively. (B) Scheme for the synthesis of pH-DIBO. 
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To fluorescently visualize proton fluxes using pH-DIBO, Chinese hamster ovary 
(CHO) cells were transiently transfected with a GFP-tagged, human voltage-gated proton 
channel (Hv1) and incubated with tetraacetylated N-azidoacetyl-D-mannosamine 
(azidosugar) [139,140]. After 2 days, the cells were labeled with pH-DIBO for 30 min 
and the currents and fluorescence were measured using patch-clamp fluorometry in a bath 
solution with a low buffer capacity (0.1 mM). Figure II-2B (left panel) shows families of 
currents and fluorescent signals from voltage-clamped CHO cells expressing Hv1; 
HEK293 cells are shown in the right panel of Figure II-2B. Voltage-activation of Hv1 
resulted in channel opening with voltage-dependent kinetics that reached a steady state 
with test voltages greater than 20 mV. Simultaneous fluorescent imaging revealed that 
the fluorescent signals mirrored both the current magnitude and kinetics of voltage-
activation at the various depolarizations. In contrast, Hv1 channel closing at – 80 mV was 
much faster than the decaying fluorescent signal, consistent with the accumulated protons 
diffusing into bulk solution. Both the voltage-dependent currents and fluorescence signals 
were specific for Hv1 channels because they were inhibited by Zn2+ (Figure II-3A) and 
required transfection with Hv1 DNA (Figure II-3B). In addition, incubation with 
azidosugar was required to observe a significant change in fluorescence upon Hv1 
channel opening (Figure II-3C and D). Cells incubated with azidosugar showed diffuse 
fluorescence over the entire cell with some higher intensity clusters (Figure II-2A, 3C and 
3D). In contrast, the fluorescent signals from vehicle-treated cells were challenging to 
detect except for a few bright puncta (Figure II-3C and 3D). Because DIBO has been 
shown to react with thiols [141], we chemically-inactivated pH-DIBO and repeated the 
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labeling experiments. Comparing TIRF images of cells labeled with chemically-inactive 
or active pH-DIBO (Figure II-3C) revealed that the punctate labeling in the absence of 
azidosugar was due to pH-DIBO non-specifically modifying the cell surface. Although 
some background labeling occurs with the DIBO group, the cells must be incubated with 
azidosugar to coat the glycocalyx with enough pH sensors to fluorescently detect cellular 
proton fluxes (Figure II-3D). 
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Figure II-2 visualization of proton efflux from CHO and HEK293 cells expressing Hv1
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Figure II-2. Visualization of proton efflux from CHO and HEK cells expressing Hv1.
(A) GFP and pH-DIBO fluorescence of CHO cells expressing Hv1. (B) Voltage-clamp 
fluorometry current and fluorescence traces of CHO (left) and HEK293 (right) cells 
expressing Hv1. Cells were held at – 80 mV, and currents and fluorescence were elicited 
from 4-s command voltages from 0 to 100 mV in 20 mV increments. (C) ∆F/F0 snapshots 
of pH-DIBO fluorescence at 100 mV at time points indicated in (B). pHo/pHi = 7.5/6.0; 
0.1 mM HEPES in bath solution. Voltage-clamp fluorometry scale bars represent 50 pA, 
2% ∆F/F0, and 1 s; fluorescent image scale bars represent 5 µm. 
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Although the observed change in fluorescence was consistent with an outward 
proton flux, we wanted to confirm that the voltage-dependent changes in fluorescence 
were due to proton accumulation on the extracellular side of the membrane. To test this, 
we increased the buffer capacity in the external bath solution to compete with 
extracellularly-facing pH-DIBO sensors (Figure II-3E). To normalize the cellular proton 
flux under each buffer condition, the cells were depolarized such that the same steady-
state current (~ 250 pA) was reached after 4 s. As expected for extracellular proton 
accumulation, increasing the buffer capacity from 0.1 to 10 mM monotonically reduced 
the change in fluorescence until no change was detectable even though Hv1 channels 
were open and conducting during the depolarizing test pulse (currents not shown). The 
competition between buffer and the glycocalyx-attached pH-DIBO sensors was also 
visualized by rapidly jumping to different depolarizing voltages and monitoring the rates 
to reach steady-state fluorescence (Figure II-4). These experiments also ruled out 
saturation of the glycocalyx-attached sensors as the cause of the steady-state fluorescence. 
To convert the steady-state fluorescence into pH at the cell surface, we varied the pH of 
the bath solution and measured the change in fluorescence (Figure II-3F). The 
fluorescence response of glycocalyx-attached pH-DIBO and pH-DIBO sensors in 
solution was linear over the same pH range, indicating that cell surface attachment did 
not appreciably change the pKa of the sensor. Thus, the 20% change in fluorescence in 
Figure II-2B corresponded to a pH of ~ 6.5 at the extracellular side of the membrane.  
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Figure II-3. Fluorescent signals require Hv1 transfection and azidosugar. Voltage-
clamp fluorometry current and fluorescence traces of Hv1-expressing CHO cells in the 
presence (left panel) or absence (middle panel) of 1 µM Zn2+ (A) and pcDNA-transfected 
CHO cells (B). Cells were held at – 80 mV, and currents and fluorescence were elicited 
from a 4-s command voltage (100 mV). pHo/pHi = 7.5/6.0; 0.1 mM HEPES in bath 
solution. Scale bars represent 50 pA, 2% ∆F/F0, and 1 s. (C) TIRF images of cells 
incubated with or without azidosugar for 48 h and treated with either pH-DIBO or 
inactivated pH-DIBO (50 µM, 30 min). pH-DIBO was inactivated by 3-azido-1-propanol 
(100 eq, 24 h). (D) Average normalized fluorescence at – 80 mV and after a 4-s 
depolarization (100 mV) in the presence (+) or absence (–) of azidosugar. Data were 
averaged from five cells; error bars are ±SEM (*p < 0.05). (E) Fluorescence traces of 
cells expressing similar total current (150-300 pA) in bath solutions with various buffer 
concentrations (HEPES), n = 5; error bars denote ±SEM. (F) Change in pH-DIBO 
fluorescence attached to the cell surface (filled circles) and in a solution (open squares) 
versus pH. Buffer concentration 10 mM; ∆F/F0 at pH 7.5 was defined as 0. Data were 
averaged from 5-10 experiments; error bars are ±SEM. 
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Figure II-4. The competition between buffer and the glycocalyx-attached pH-DIBO 
sensors. Voltage-clamp fluorometry current and fluorescence traces of Hv1-expressing 
CHO cells for a series of voltage step-ups (left) and step-downs (right). Scale bars 
represent 100 pA, 2% ∆F/F0 and 2 s; pHo/pHi = 7.5/6.0, 0.1 mM HEPES in bath solution. 
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One component of the fluorescent signal that could not be easily explained was 
the biexponential decay kinetics that were observed when the channels were closed by 
repolarization (Figure II-2B, 3A, 3E, 4 and 5). The slower time constant was consistent 
with proton diffusion because it was dependent on buffer concentration (Figure II-3E); 
however, the initial drop in fluorescence was independent of buffer concentration. We 
initially dismissed inward proton currents through Hv1 channels because the outward 
proton gradient used would require hyperpolarization less than – 90 mV. However, it has 
been recently shown that Hv1 channels can deplete the local proton concentration on the 
intracellular side of the channel [39], raising the possibility that the local proton driving 
force could be vastly different than the bulk proton gradient. Indeed, holding Hv1 
channels open for 4 s at 100 mV in the absence of a pH gradient created a substantial 
inward proton gradient, which was detected as an inward tail current when the channels 
were closed at 0 mV (Figure II-5, blue trace). Under these experimental conditions, the 
fast component of the fluorescent decay was directly proportional to the channel closing 
rate, demonstrating that the initial drop in fluorescence was in fact due to protons re-
entering the cell through Hv1 channels before they closed (Figure II-5).  
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Figure II-5. Tail currents and pH-DIBO fluorescence decay at different closing 
voltages. Cells were held at – 80 mV, depolarized to 100 mV, and tail currents were 
elicited at 0 mV (blue), – 40 mV (red), and – 80 mV (black). Current and fluorescence 
traces of the entire voltage protocol are shown on the left. Scale bars represent 50 pA, 2% 
∆F/F0 and 2 s. The tail regions are enlarged on the right. Scale bars represent 25 pA, 2% 
∆F/F0 and 0.5 s. No pH gradient was used: pHo/pHi = 7.0/7.0, 0.1 mM HEPES in bath 
solution. 
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We next examined whether the pH-DIBO signals correlated with Hv1 channel 
localization by comparing the whole-cell fluorescent images. The pH-DIBO fluorescent 
image shows diffuse staining over the entire cell surface, though some large clusters of 
sensors were always observed as shown in the exemplar in Figure II-2A. Surprisingly, 
Hv1 channel localization was similar to pH-DIBO labeling, including the overlapping 
smiley emoji observed in both panels (Figure II-2A). Because Hv1 channels cannot be N- 
or O-glycosylated (they do not contain any extracellular serines or threonines), we 
hypothesized that the unusual convergence was due to pinocytosis of pH-DIBO-labeled 
glycoproteins into acidic compartments that overlapped with intracellular Hv1 channels. 
Although the images collected contained both in- and out-of-focus light, we used the 
voltage-dependent change in the pH-DIBO signal to isolate the population of sensors that 
were facing the extracellular milieu. Figure II-2C shows three F – F0 snapshots before, 
during, and after a 100-mV test pulse (Movie II-1). In contrast to the clusters observed in 
Figure II-2A, the pH-DIBO signal in these processed images was scattered over the entire 
cell, indicating that functioning Hv1 channels were not clustered, but were randomly 
distributed over the cell surface. 
Disentangling Proton Efflux from Ionic Currents 
To characterize the glycocalyx-attached pH sensors, we used a perfectly proton 
selective channel, Hv1 [30], However, many membrane transport proteins permit the 
simultaneous passage of a proton with a different ion or ions, which will contaminate or 
completely obscure the proton current. Omega currents from voltage-gated cation 
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channels are a class of proton currents that have been postulated to cause several human 
diseases [46–48,50], but have not been observed without destroying or blocking the ion 
conducting pore domain. Therefore, we used our approach to determine whether these 
gain-of-function voltage sensor domain mutations create omega proton currents in a 
channel with a functioning central pore. For the omega proton current, we used a Shaker-
IR K+ mutant (R371H) [45], which is expected to form four voltage-dependent proton 
pores that circumscribe the central potassium pore (Figure II-6A). Figure II-6B shows 
current traces and fluorescent signals from cells expressing Shaker-IR R371H and WT 
channels. Depolarization-elicited Shaker-IR R371H currents activated rapidly and slowly 
inactivated over the 4-s depolarization. The rapid activation kinetics, large currents, and 
hallmark voltage-dependent C-type inactivation indicated that the majority of the current 
was flowing through the central pore. In contrast to the current traces, the changes in pH-
DIBO fluorescence were indicative of a small, but relatively constant voltage-dependent 
proton current that modestly lowered the extracellular pH. Using the calibration in Figure 
II-3F, the ~ 3% change in fluorescence at the end of the 120-mV pulse equated to a ~ 
0.05 pH change on the extracellular side of the membrane. No omega proton fluxes were 
fluorescently detected with WT Shaker-IR, which expressed 10-fold more total current 
than the R371H mutant and had unusual inactivation kinetics with a 120 mV 4-s 
depolarization.  
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Figure II-6. Visualization of proton efflux from co-transport proteins expressed in 
CHO cells. (A) Cartoons of Hv1, ClC-5 and Shaker omega mutant (R371H). (B) 
Voltage-clamp fluorometry current and fluorescence traces of cells expressing Shaker-IR 
R371H (scale bars: 100 pA, 1% ∆F/F0, 1 s) from 0 to 120 mV in 40-mV increments and 
WT Shaker-IR at 120 mV (scale bars: 1 nA, 1% ∆F/F0, 1 s); holding potential – 80 mV, 
pHo/pHi = 7.5/6.0, 0.1 mM HEPES in bath solution. (C) Voltage-clamp fluorometry 
current and fluorescence traces of cells expressing ClC-5 from 60 to 140 mV in 20-mV 
increments and ClC-5 E211A at 140 mV. Holding potential – 80 mV; pHo/pHi = 7.5/7.5, 
0.1 mM HEPES in bath solution. Scale bars represent 50 pA, 2% ∆F/F0, and 1 s. (D) Plot 
of ∆F/F0 as a function of current for Hv1 and ClC-5.  
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Because we could specifically visualize proton efflux in the presence of a 
functioning potassium pore, it was possible to calculate the omega proton current’s 
contribution to the total current. To convert the pH-DIBO signal into current, we needed 
to determine whether the fluorescent signal could serve as a surrogate for the whole-cell 
proton current. Therefore, we compared the current traces and fluorescent signals from 
cells expressing the ClC-5 antiporter that transports two chloride ions for every exported 
proton (Figure II-6A) [67]. Cells expressing ClC-5 gave rise to near instantaneous 
voltage-dependent currents that do not inactivate (Figure II-6C). Both the magnitude and 
rate of F/F0 proportionally increased with the total current, indicating that a constant 
proton source was activated with depolarization. These changes in fluorescence were 
proton-specific because they were not observed with a ClC-5 mutant (E211A) [63] that 
only conducts chloride (Figure II-6C, lower panels). To calibrate the fluorescent signals, 
we plotted the linear fits of F/F0 vs. current for Hv1 and ClC-5 expressing cells (Figure 
II-6D) and found that the slope of the ClC-5 data was approximately 1/3rd of Hv1. 
Because the fluorescent pH-DIBO signal was directly proportional to the whole-cell 
proton current, the maximum change in fluorescence for Shaker-IR R371H corresponded 
to ~ 40 pA of proton current (Figure II-6B). Thus, the omega proton current is only 6% of 
the total Shaker-IR R371H current. 
Visualizing Extracellular Proton Depletion and Proton Wavefronts  
In addition to the selective visualization and quantification of proton efflux in the 
presence of other ion currents, glycocalyx-attached pH-DIBO sensors should faithfully 
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report on changes in proton concentration at the cell surface regardless of the proton 
source or direction. Therefore, we labeled cells expressing Shaker-IR R362H [32] with 
pH-DIBO to visualize inward proton currents at hyperpolarizing potentials (Figure II-7A). 
To directly compare the inward fluorescent signals to the outward Hv1 signals, we 
intentionally blocked the potassium channel pore (W434F) [142]; thus, the currents 
shown in Figure II-7A are only omega currents. The change in fluorescence with Shaker-
IR R362H was the mirror opposite to Hv1 (Movie II-3): the cell surface fluorescence 
became dimmer upon hyperpolarization, reached steady-state, and then rapidly recovered 
with biexponential kinetics when the cell was returned to the 30-mV holding potential 
(Figure II-7A, bottom panel). In addition, the absolute value of the current-F/F0 slope 
(0.82 ± 0.09) was similar to Hv1, indicating that Shaker-IR R362H is a proton selective 
omega current that readily depletes protons on the extracellular side of the membrane.  
While performing the proton flux experiments, we noticed the pH-DIBO-labeled 
cells adjacent to the patch-clamped cell fluoresced with a delayed synchrony, as if the 
neighboring cells were reporting on the proton efflux of the depolarized cell (Movie II-5). 
To test this supposition, we measured the change in fluorescence on each half of a 
neighboring cell (near and far) and plotted it against the voltage-clamped cell expressing 
Hv1 channels (Figure II-7B). The clamped, near, and far fluorescent signals were 
consistent with a proton wavefront originating from the clamped cell that first reached the 
near side of the adjacent cell and then gradually enveloped the far side of the cell. After a 
4-s depolarization, the extracellular proton concentration was the greatest around the 
clamped cell, but a substantial proton gradient was also detected over the surface of the 
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neighboring cell that was four microns away. Upon turning off the proton source 
(clamped cell), the extracellular proton gradient across the neighboring cell decayed with 
a single time constant (Figure II-7B, right panel), reaffirming that the rapid drop in 
fluorescence observed with the patch-clamped cells was due to protons rapidly entering 
the cytoplasm before Hv1 channel closure. As expected for an extracellular proton 
wavefront, the pH surrounding a neighboring cell was titratable with buffer concentration 
(Figure II-7C). In total, these data demonstrated that the glycocalyx-attached pH-DIBO 
sensors exquisitely report on the extracellular pH at the plasma membrane, enabling the 
visualization of both proton fluxes and wavefronts. 
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Figure II-7. Visualization of extracellular proton depletion and wavefronts in CHO 
cells. (A) Voltage-clamp fluorometry traces of cells expressing Shaker-IR R362H/W434F. 
Cells were held at 30 mV, and currents and fluorescence were elicited from 4-s command 
voltages from – 40 to – 120 mV in 20-mV increments. pHo/pHi = 6.0/7.5, 0.1 mM MES 
in bath solution. Scale bars represent 50 pA, 2% ∆F/F0, and 1 s. (B) Left: cartoon of 
proton diffusion to a neighboring cell. Right: fluorescent signals of pH-DIBO-labeled 
cells. A voltage-clamped Hv1-expressing cell (– 80 mV) was depolarized to 100 mV and 
the fluorescent signals from the clamped (d = 23 µm) and a neighboring cell (near and far 
side, d = 18 µm) were plotted versus time. The distance of the two cells is ~ 4 µm. 
pHo/pHi = 7.5/6.0, 0.1 mM HEPES in bath solution. Scale bars represent 2% ∆F/F0 and 1 
s. (C) Buffer concentration dependence of the fluorescent signals of a neighboring cell ~8 
µm away from an Hv1-expressing cell. The clamped cells were held at – 80 mV, 
depolarized to 100 mV, and the fluorescence of the clamped and neighboring cells were 
plotted versus time. pHo/pHi = 7.5/6.0, 0.1 or 1mM HEPES in bath solution. Scale bars 
represent 2% ∆F/F0 and 1 s. (D) Cartoon and proton diffusion equation of the concentric 
volume model with an unstirred layer (USL). (E) Fits of the fluorescent data in (A). Bulk 
= 1 mL; USL = 1.5 fL; shell = 0.08 fL; KUSL = KB = 1; kf = kr = 1. 4 s-1; kin (black) = 
0.090 s-1; kin (red) = 0.070 s-1; kin (blue) = 0.050 s-1; kin (magenta) = 0.030 s-1; kin (green) 
= 0.013 s-1. 
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Discussion 
By covalently attaching small molecule pH-sensitive fluorophores (pH-DIBO) 
directly to the cell’s glycocalyx, we observed both inward and outward proton fluxes, 
extracellular pH gradients, and proton wavefronts enveloping neighboring cells. 
Although a subpopulation of sensors is internalized, these luminally-facing fluorescent 
sensors are unresponsive to plasma membrane activity. As designed, the glycocalyx-
attached pH-DIBO sensors did not report on ion channel gating or transporter 
activation/deactivation, but rather the kinetics of proton accumulation or depletion on the 
extracellular side of the membrane. The juxtaposition of the covalently-attached pH-
DIBO sensors to the extracellular vestibules of membrane transport proteins provided 
remarkable insight into the extracellular pH environment abutting a mammalian cell. 
Previous determinations of extracellular pH at the cell surface required either extremely 
large cells [67] or mathematical modeling [41] to estimate the radiating pH gradient. Our 
results suggest that Hv1 proton channels create a much more acidic extracellular 
environment than was previously calculated. For example, the pH surrounding the 
clamped cell in Figure II-7B is ~ 6.3 whereas the calculation [41] for a similarly-sized 
spherical cell is ~ 7.2. Part of the difference may be due to limited proton diffusion in the 
restricted space between the cell and the glass coverslip. However, the pH gradient (6.8 – 
7.2) observed across neighboring cells indicates that the majority of the protons 
emanating from a patch clamped cell are freely diffusing in the bath solution. These 
proton accumulation and diffusion results also highlight that open Hv1 channels not only 
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deplete the local intracellular proton concentration [39], but also raise the extracellular 
proton concentration tens of microns away from the cell perimeter. 
Because the glycocalyx-attached pH sensors are well within the experimentally 
and computationally determined unstirred layer (USL) for protons [143], our approach 
provides an opportunity to monitor proton diffusion over the entire cell surface during 
proton transport. The slow opening and closing of Hv1 channels confounds modeling 
these data; however, the fluorescent data from the rapidly closing Shaker-IR R362H 
omega pores (Figure II-7A) are amenable to fitting. Proton depletion from the glycocalyx 
shell upon channel opening could be well fitted with a simple equation: 
[cell]
         𝑘𝑖𝑛      
←      [shell]
      𝐾𝐵      
←     [bulk] 
where shell corresponded to the approximate volume of the cell’s glycocalyx, KB 
was the proton equilibrium constant between bulk and shell, and kin correlated with the 
steady state current at each depolarizing voltage. However, upon channel closing, the 
model failed to recapitulate the slow phase of the biphasic kinetics of proton replenishing 
shown in Figure II-7A (bottom panel); therefore, an additional layer (USL) and 
equilibrium constant (KUSL) between the glycocalyx shell and an unstirred layer was 
added to the model (Figure II-7D). For the modeling, we varied kin, the volumes of the 
USL and shell, and the rate of proton entry and exit into a layer. In addition, we assumed 
the equilibrium constant between any layer was equal to one and the forward and 
backward proton rates into a layer (shell, USL, and bulk) was the same. At each voltage 
(Figure II-7E), kin was varied to achieve the steady state fluorescence after 4 s, which 
correlated well with the total number of protons that entered the cell (average current) 
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during the hyperpolarizing pulse (Figure II-7A, top panel). In contrast to the simple shell 
model, this concentric volume model fit the biphasic return of protons to the glycocalyx 
shell (Figure II-7E). Because kin was held constant at each voltage, the model poorly fit 
the kinetics of proton influx at hyperpolarizing voltages where channel gating, and thus 
current, was not constant during the test pulse (Figure II-7A, top panel). In addition, the 
local proton concentration in the shell and equilibrium between the layers is likely more 
complicated due to the cell surface proteins, carbohydrates, and covalently-bound pH 
sensors in the glycocalyx. 
Although we could fit the fluorescent signal kinetics of proton replenishing at the 
cell surface, the model does not speak to how the unstirred layer fills (or empties) during 
proton transport. Several studies [144–147] suggest that during proton efflux the protons 
diffuse rapidly and parallel to the plasma membrane before entering the unstirred layer 
and bulk solution. The neighboring cell experiments in Figure II-7B and C demonstrate 
that it is experimentally feasible to utilize glycocalyx-attached pH sensors to 
spatiotemporally detect pH differences at the plasma membrane. However, in our 
experiments, the proton channels and transport proteins were randomly distributed over 
the entire cell surface; thus, we did not detect rapid proton diffusion parallel to the plasma 
membrane upon activating proton efflux with voltage. Visualization of proton efflux from 
a proton transport protein that localizes to a specific region of the plasma membrane 
would provide insight on whether protons rapidly circumscribe a living cell before 
diffusing into the unstirred layer and bulk solution.  
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An unexpected advantage of directly attaching the sensors to the glycocalyx was 
that the change in pH-DIBO fluorescence was an accurate approximation of the whole 
cell proton current in voltage-clamp experiments. By comparing the ClC-5 current-F/F0 
slope to Hv1, we showed that only 1/3rd of the ClC-5 current is carried by protons, fully 
consistent with the known 2:1 stoichiometry of its transport cycle [67]. In contrast to 
ClC-5, Shaker-IR omega currents were as proton-selective as Hv1 channels. Using the 
current-F/F0 relationship, we estimated that the proton current accounted for ~ 6% of 
the total current for a Shaker-IR VSD omega mutant. If all four VSDs pass the same 
amount of proton current, then our experimental results indicate that a single omega pore 
contributes 1 - 2% of the total current in a voltage-gated K+ channel. Because VSD 
mutations affect the potassium current through the central pore by shifting the voltage-
activation, deactivation, and inactivation of the channel, we expect the proton current’s 
contribution to the total current will vary for the different omega pore mutants that cause 
human disease. No proton fluxes were ever observed with wild-type voltage-gated K+ 
channels, confirming that the histidine residues in the VSDs are required for the omega 
current in full-length Shaker-IR channels. In addition to being a surrogate for proton 
current, voltage-clamp fluorometry with pH-DIBO will also be useful for identifying 
residues required for proton permeation and exploring the voltage-dependency of non-
electrogenic proton transport proteins.  
Because proton transport is involved in a wide range of cellular processes, 
chemical tools that specifically detect plasma membrane proton fluxes have broad utility. 
The diverse color and pKa palette of small molecule proton sensors [134] provide 
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additional flexibility to coat cells with fluorophores with desirable pH-sensing and 
photophysical properties. Combining our chemical approach with state-of-the-art imaging 
techniques will allow for high-resolution spatiotemporal imaging over the entire 
landscape of a cell and possibly visualization of single-channel fluxes. Given that the 
glycocalyces of living organisms can be engineered with unnatural sugars [126,148,149], 
visualization of rapid efflux from cells, tissues, and model organisms is tenable by 
modifying metabolically-labeled glycocalyces with small molecule ion- or metabolite-
sensitive fluorophores.  
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Material and Methods 
Molecular Biology 
Plasmids containing human Hv1, ClC5, and Shaker-IR omega mutants were gifts 
from David Clapham (Harvard Medical School), Michael Pusch (Istituto di Biofisica), 
and Baron Chanda (University of Wisconsin–Madison), respectively. Mutations were 
introduced by QuikChange site-directed mutagenesis (Agilent) and confirmed by DNA 
sequencing the entire gene. 
Cell Culture, Transfections and pH-DIBO Cell Surface Labeling 
Chinese Hamster Ovary-K1 (CHO-K1) cells were cultured in F-12K nutrient 
mixture (Invitrogen); HEK293 cells were cultured in high glucose DMEM medium. All 
media were supplemented with 10% fetal bovine serum (Hyclone) and 100 units/mL 
penicillin/streptomycin (Invitrogen). The cells were plated at 60 ~ 75% confluency in 35 
mm dishes. Glass bottom culture dishes (MatTek) were used for HEK293 cells. After 24 
h, cells were transiently transfected with 1 g of ion channel or transporter DNA and 8 
L of Lipofectamine (Invitrogen) for CHO cells or 4 L of Lipofectamine and 6uL 
PLUSTM reagent (Invitrogen) for HEK293 cells in Opti-MEM (Invitrogen). To visualize 
transfected cells, 0.25 g of pEGFP-C3 was added to transfections that did not contain 
GFP-tagged channels/transporters. After terminating the transfections, the cells were 
incubated in media containing 50 M azido-sugar for 2 days, which was replenished after 
24 hrs.  
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Whole Cell Patch Clamp Fluorometry  
Transfected CHO cells were trypsinized and seeded on a glass bottom culture dish 
for 2 hrs and then labeled with pH-DIBO (50 M) in Opti-MEM at r.t. for 30 min; 
HEK293 cells were directly labeled with pH-DIBO in Opti-MEM. Transfected cells were 
identified using an inverted light microscope (Axiovert 40 CFL; Carl Zeiss, Inc.) and the 
currents were recorded in the whole cell patch configuration at room temperature (24 ± 
2°C) using a glass electrode (pipette resistance: 2.5 – 3.5 MΩ) filled with (in mM): 126 
KCl, 2 MgSO4, 0.5 CaCl2, 5 EGTA 4 K2-ATP, 0.4 GTP and 25 buffer (HEPES for pH = 
7.5 and 7.0, MES for pH = 6.0) with KOH; bath solution contained (in mM): 145 NaCl, 
5.4 KCl, 5 CaCl2, 0.1 buffer (TAPS for pH = 8.0, HEPES for pH = 7.5 and 7.0, Bis-Tris 
for pH = 6.5, MES for pH = 6.0) with NaOH. Cells were imaged at 10 Hz using a 
CoolLED pE-4000 light source, 63 x 1.4 N.A. oil immersion objective, and a Zyla 
sCMOS camera (ANDOR). The patch clamp (Axopatch 200B), light source, and camera 
were controlled with Clampex 10.5 (Molecular Devices); fluorescent images were 
collected (10 Hz) and processed using open source software (micro-manager and ImageJ). 
F0 is the average fluorescence intensity of first five data points. 
TIRF Imaging 
Images were acquired with an Olympus IX71 microscope with a 60 X 1.49 
Olympus objective and a 1.6 X optivar with TIRF illumination. Exposure was set to 100 
ms and the excitation light was provided by a Colbolt Jive 561 laser set to 20 mW. 
Emitted light was first passed through a dual dichroic (525/50 nm, 645/140 nm) and then 
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a 525/50 nm band-pass. An Andor iXon EM+ 885i CCD (1004 X 1002 with 8 mM 2 
pixels) was used to collect the light. 
Synthesis Procedures 
Tetraacetylated N-Azidoacetyl-D-Mannosamine (azidosugar), and 5,6-dihydro-
11,12-didehydro-dibenzo[a,e]cycloocten-5-yl ester, 4-nitrophenyl ester (DIBO-4-
nitrophenyl ester), and Compound 1 were synthesized and purified as previously 
described.  
Unless otherwise stated, all other reactions were run under an inert environment 
of argon (Ar) from which water and oxygen were rigorously excluded. 
Pentafluorobenzaldehyde and methanesulfonic acid were purchased from Acros. 3-(1-
Piperazinyl) phenol was from Alfa Aesar. All other reagents and solvents were obtained 
from Sigma-Aldrich. Deuterated solvents were purchased from CIL. Thin layer 
chromatography was used to monitor the progress of reactions with EM Science silica gel 
60 F254 plates or neutral aluminum oxide F254 plates from EMD Chemicals. Flash 
chromatography was performed using silica gel 60 (40-63 μm) from BDH. The final 
compound was purified by HPLC using a Higgins Analytical PROTO 300 C-18 column 
(10 µm), 250 × 10 mm (RS-2510-W181) on a Hewlett Packard Agilent 1100 HPLC 
instrument equipped with G1315A DAD absorbance detector. NMR spectra were 
recorded in CDCl3, CD3OD on a Varian 400 MHz spectrometer; 
1H NMR and 13C NMR 
signals are reported in chemical shift relative to the NMR solvent peak; 19F NMR are 
reported in chemical shift relative to an internal triflouroacetic acid (TFA) standard. 
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Coupling constants are reported as J values in Hz. NMR splitting patterns are abbreviated 
as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Coupling 
constants (J) are reported in Hz. High resolution mass spectra (HRMS) were obtained on 
a Waters Q-TOF Premier Mass Spectrometer at the University of Massachusetts Medical 
School Proteomics and Mass Spectrometry Laboratory. Fluorescence spectroscopic 
measurements were performed on an F4500 (Hitachi). 
Compound 2 (Boc-pH) 
 
Crude 1 was synthesized following procedure described in the literature without 
further purification. Di-tert-butyl dicarbonate (4g, 18 mmol) was added to a stirred 
solution of crude 1 (4 g) and NaHCO3 (2.7 g, 32 mmol) in H2O (100 mL). After being 
stirred at r.t. overnight, the reaction mixture was extracted with CH2Cl2 (3 x 100 mL). 
The combined organic layers were washed with H2O (3 x 100 mL), dried (Na2SO4), 
filtered and the filtrate was concentrated under reduced pressure. The crude product was 
purified by chromatography over silica gel (50:1, v/v, CH2Cl2/Methanol) to give 
compound 2 (1.54 g, two steps yield 28%). 1H-NMR (400 MHz, CD3OD) δ = 7.53 (d, J = 
9.6 Hz, 2H), 7.36 (dd, J = 9.6, 2.4 Hz, 2H), 7.25 (d, J = 2.4 Hz, 2H), 3.93 – 3.84 (m, 8H), 
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3.68 (s, 8H), 1.50 (s, 18H). 19F-NMR (376 MHz, CD3OD) δ = -138.80 (d, J = 17.6 Hz, 
2F), -150.66 (t, J = 20.3 Hz, 1F), -160.47 (dt, J = 20.3, 5.6 Hz, 2F). 13C-NMR (101 MHz, 
CD3OD) δ = 159.58, 158.91, 156.17, 131.93, 117.14, 115.59, 98.82, 81.91, 48.06, 28.60. 
HRMS (ESI): m/z calculated for C37H40F5N4O5 (M
+): 715.2913; found: 715.2890. 
Compound 3 (Boc-pH-COOH) 
 
Compound 2 (580 mg, 0.8 mmol), N,N-dimethylacetamide (25 mL) and 
trimethylamine (720 L) were heated to 50 ℃ and 3-mercaptopropionic acid (100 L) 
was added dropwise. After being stirred at 50 for 3h, the solvents were evaporated under 
reduced pressure. The residue was dissolved in CH2Cl2 (100 mL) and the resulting 
solution was washed with H2O (3 x 50 mL), which was back extracted with CH2Cl2 (3 x 
30 mL). The combined organic layers were dried with Na2SO4, filtered and concentrated 
under reduced pressure. The crude was purified by chromatography over silica gel (50:1 -> 
10:1, v/v, CH2Cl2/Methanol) to give compound 3 (0.3 g, 46%). 
1H NMR (400 MHz, 
CD3OD) δ = 7.54 (d, J = 9.5 Hz, 2H), 7.36 (dd, J = 9.5, 2.4 Hz, 2H), 7.26 (d, J = 2.4 Hz, 
2H), 3.95 – 3.81 (m, 8H), 3.68 (s, 8H), 3.39 – 3.33 (m, 2H), 2.73 – 2.64 (m, 2H), 1.50 (s, 
18H). 19F-NMR (376 MHz, CD3OD) δ = -131.87 (2F, dd, J = 25.8, 12.4 Hz, 2F), -138.96 
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(dd, J = 26.8, 14.5 Hz, 2F). 13C NMR (101 MHz, CD3OD) δ = 159.52, 158.85, 156.16, 
132.04, 117.14, 115.38, 98.84, 81.86, 48.06, 31.25, 28.60. HRMS (ESI): m/z calculated 
for C40H45F4N4O7S (M
+): 801.2940; found: 801.2933.  
Compound 4 (Boc-pH-NH2) 
 
N,N-Diisopropylethylamine (90 mg, 0.7 mmol) and 1-
[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid 
hexafluorophosphate) (171 mg, 0.45 mmol) was added slowly to a stirred solution of 
compound 3 (300 mg, 0.37 mmol), 2, 2’-(Ethylenedioxy) bis(ethylamine) (555 mg, 3.7 
mmol), DMF (5mL) and CH2Cl2 (5 mL) at 0 ℃. After being stirred at r.t. for 2 h, the 
solvents were evaporated under reduced pressure. The residue was dissolved in CH2Cl2 
(50 mL) and the resulting solution was washed with brine (3 x 50 mL) and H2O (3 x 50 
mL) which were back extracted with CH2Cl2 (3 x 30 mL). The combined organic layers 
were dried (Na2SO4), filtered and concentrated under reduced pressure. The crude was 
purified by chromatography over silica gel (50:1 -> 10:1, v/v, CH2Cl2/Methanol) to give 
compound 4 (0.2 g, 57%). 1H NMR (400 MHz, CD3OD) δ = 7.58 (d, J = 9.6 Hz, 2H), 
7.38 (dd, J = 9.6, 2.4 Hz, 2H), 7.26 (d, J = 2.4 Hz, 2H), 3.93 – 3.82 (m, 8H), 3.72 – 3.64 
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(m, 12H), 3.58 (t, J = 5.7 Hz, 4H), 3.37 (dd, J = 9.7, 4.1 Hz, 4H), 3.11 – 3.05 (m, 2H), 
2.67 (t, J = 6.8 Hz, 2H), 1.50 (s, 18H). 19F NMR (376 MHz, CD3OD) δ = -131.63 (dd, J 
= 25.1, 12.6 Hz, 2F), -138.89 (dd, J = 24.5, 11.9 Hz, 2F). 13C NMR (101 MHz, CD3OD) 
δ = 173.21, 159.57, 158.90, 156.18, 117.11, 115.41, 98.82, 81.92, 71.35, 70.55, 67.93, 
48.06, 40.67, 40.31, 37.46, 31.52, 28.60. HRMS (ESI): m/z calculated for 
C46H59F4N6O8S (M
+): 931.4046; found: 931.4034.  
Compound 5 (Boc-pH-DIBO) 
 
DIBO-4-nitrophenyl ester (196 mg, 0.51 mmol) was added to a stirred solution of 
compound 4 (240 mg, 0.26 mmol) and triethylamine (36 L, 0.26 mmol) in CH2Cl2 (30 
mL). After being stirred at r.t. for 16 h, the solvent was evaporated under reduced 
pressure. The residue was dissolved in CH2Cl2 (50 mL) and the resulting solution was 
washed with H2O (3 x 50 mL), which was back extracted with CH2Cl2 (3 x 30 mL). The 
combined organic layers were dried with Na2SO4, filtered and concentrated under 
reduced pressure. The crude was purified by chromatography over silica gel (50:1 -> 20: 
1, v/v, CH2Cl2/Methanol) to give compound 5 (110 mg, 36%). 
1H NMR (400 MHz, 
CD3OD) δ = 7.48 (dd, J = 12.3, 8.7 Hz, 4H), 7.35 – 7.21 (m, 8H), 7.14 (d, J = 2.1 Hz, 2H), 
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5.29 (s, 1H), 3.89 – 3.77 (m, 8H), 3.63 (d, J = 6.2 Hz, 12H), 3.54 (t, J = 5.1 Hz, 4H), 3.37 
– 3.33 (m, 4H), 3.26 (t, J = 5.2 Hz, 2H), 3.12 (dd, J = 15.1, 2.1 Hz, 1H), 2.68 (dd, J = 15.1, 
3.9 Hz, 1H), 2.60 (t, J = 6.7 Hz, 2H), 1.51 (s, 18H). 19F NMR (376 MHz, CD3OD) δ = -
131.27 (dd, J = 27.3, 14.7 Hz, 2F), -138.41 (dd, J = 26.8, 14.2 Hz, 2F). 13C NMR (101 
MHz, CDCl3) δ = 171.40, 158.10, 157.33, 155.94, 154.44, 152.42, 151.37, 132.65, 
130.24, 128.17, 128.14, 126.97, 126.94, 126.02, 125.84, 124.36, 123.78, 121.09, 116.32, 
114.74, 112.90, 110.12, 97.45, 81.07, 70.46, 70.34, 70.22, 70.05, 47.19, 46.24, 40.99, 
39.22, 36.61, 30.43, 28.48. HRMS (ESI): m/z calculated for C63H69F4N6O10S (M+): 
1177.4727; found: 1177.4729.  
Compound 6 (pH-DIBO) 
 
Trifluoroacetic acid (5mL) was added dropwise to a stirred solution of compound 
5 (100 mg, 0.085 mmol) in CH2Cl2 (5 mL), H2O (1 mL). After being stirred at r.t. for 1.5 
h, the solvents were evaporated under reduced pressure. The residue was dissolved in 
H2O (25 mL) and the resulting solution was washed with CH2Cl2 (3 x 20 mL). The 
aqueous layers were concentrated under reduced pressure and purified by HPLC. 25 mg 
crude yielded 15 mg pure compound 6. If up-scaled, 60 mg (0.051 mmol, 72%). 1H NMR 
(400 MHz, CD3OD) δ = 7.59 (d, J = 9.5 Hz, 2H), 7.51 (d, J = 7.9 Hz, 1H), 7.38 (d, J = 9.6 
61
Hz, 3H), 7.33 (s, 4H), 7.30 – 7.24 (m, 4H), 5.31 (s, 1H), 4.07 (d, J = 4.6 Hz, 8H), 3.62 (s, 
4H), 3.54 (d, J = 2.6 Hz, 4H), 3.44 (d, J = 4.7 Hz, 8H), 3.35 (m, 4H), 3.27 (t, J = 5.5 Hz, 
2H), 3.15 (dd, J = 15.1 Hz, 1H), 2.75 – 2.67 (m, 1H), 2.61 (t, J = 6.7 Hz, 2H). 19F NMR 
(376 MHz, CD3OD) δ = -132.77 (dd, J = 27.2, 14.4 Hz, 2F), -139.95 (dd, J = 27.1, 14.4 
Hz, 2F). 13C NMR (126 MHz, CD3OD) δ = 173.04, 159.86, 158.97, 157.95, 153.54, 
152.46, 145.26, 132.40, 131.09, 129.32, 129.26, 128.29, 128.26, 127.19, 126.91, 124.99, 
124.88, 122.26, 117.57, 116.14, 113.78, 110.97, 99.66, 77.87, 71.37, 71.30, 70.94, 70.51, 
47.19, 45.34, 44.04, 41.76, 40.43, 37.62, 31.41. HRMS (ESI): m/z calculated for 
C53H53F4N6O6S (M
+): 977.3678; found: 977.3669.  
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CHAPTER III. VISUALIZATION OF PROTON FLUXES FROM MCT1 AND 
IDENTIFICATION OF HRM, A PROTON-COUPLED MONOCARBOXYLATE 
TRANSPORTER IN DROSOPHILA 
Summary 
The transport of monocarboxylates, such as lactate and pyruvate, is essential for 
cellular metabolism and is mainly mediated by proton-coupled monocarboxylate 
transporters (MCT1-4). There are ten other MCTs in mammals: MCT6 and MCT11 are 
proton-coupled transporters; the others are either non-proton-coupled (MCT8-10) or 
orphan transporters (MCT12-14). Although pH electrodes and intracellular pH sensors 
have been widely used for measuring the transport of proton-coupled MCTs, they provide 
limited information about the subcellular activities and underestimate the transport rate. 
Here we used the approach developed in Chapter II to monitor proton fluxes from MCT1 
at the cell surface. Upon extracellular perfusion of L-lactate or pyruvate, we observed 
proton depletion followed by a rapid recovery over the entire landscape of cells 
expressing MCT1. Furthermore, we demonstrated that the membrane protein in 
Drosophila, Hrm, which has been implicated in autophagy, is a proton-coupled MCT that 
preferentially transports pyruvate.  
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Introduction 
Monocarboxylates play a major role in cellular metabolism. For example, 
pyruvate, a product of glycolysis, is used as an energy source for cells. In anaerobic 
conditions, pyruvate is converted into lactate which can then negatively regulate 
glycolysis when intracellular concentrations increase [150]. Furthermore, lactate and 
ketone bodies can be oxidized as respiratory fuels in the heart, brain and red skeletal 
muscle [73]. Monocarboxylate transport in and out of cells is mainly mediated by proton-
coupled monocarboxylate transporters (MCT1-4) encoded by the SLC16 family of genes 
in mammals. 
Besides MCT1-4, there are ten other MCTs: MCT11 has been shown to be a 
proton-coupled pyruvate transporter implicated in type 2 diabetes [93]; MCT6 facilitates 
the proton-coupled transport of bumetanide, but its natural substrate remains unknown 
[94]; MCT7 is involved in the hepatocyte secretion of ketone bodies during fasting but 
has not been functionally characterized [98]; MCT8-10 transport thyroid hormones, 
carnitines and aromatic amino acids, respectively and are not proton-coupled [95–97]. 
The substrates and functions of MCT12-14 are currently unknown. 
In Drosophila melanogaster, there are 14 genes belonging to the SLC16 family. 
However, only two of them have been functionally characterized. Sln/dMCT1 mediates 
transport of butyrate and lactate and is crucial for triggering LKB1 dependent apoptosis 
[99]. The second gene, Chaski, which is enriched in glial cells has been identified as a 
lactate/pyruvate transporter [100]. The Baehrecke laboratory at UMMS has identified 
CG11665/hrm, a gene that shows significant sequence similarity to SLC16 genes. They 
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found that Hrm is required for both autophagy during steroid-triggered salivary gland cell 
death and TNF-induced non-apoptotic eye cell death (unpublished). However, it is still 
unknown whether Hrm functions as a proton-coupled MCT or what its substrates are. 
As the transport of proton-coupled MCTs is non-electrogenic, it is difficult to use 
electrical recordings to monitor their activities. Radiolabeled substrates are commonly 
used for the activity measurement due to their high specificity and sensitivity [73]. The 
transport rate is measured by determination of intracellular labeled substrates after rapid 
termination. However, the diffusion and metabolism of substrates during the procedures 
may generate substantial errors. In recent years, genetically encoded fluorescent sensors 
have been introduced for the real time measurement of intracellular substrates, such as 
pyruvate and lactate [105,106], but their KD values limit the detectable concentration 
range of substrates. Because the activities of MCT1-4 are associated with proton 
transport, they also have been measured by monitoring pHi using pH-sensitive dyes, such 
as BCECF-AM [73]. Although these tools enable the real-time measurement of transport, 
they provide limited spatial-information and underestimate the transport rate due to the 
cell’s volume and intracellular buffering. Many of these constraints can be overcome by 
visualizing changes in extracellular pH. 
Here, we used the approach developed in Chapter II to detect proton fluxes from 
MCT1 expressed in HEK293T cells. Upon addition and removal of extracellular L-lactate 
or pyruvate, we observed a rapid decrease in fluorescence followed by a fast recovery 
corresponding to proton fluxes and diffusion. The kinetics of proton depletion and 
accumulation at the cell surface revealed MCT1 activity in real time. Moreover, Hrm, 
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which was implicated in mTOR-regulated autophagy in Drosophila, was identified as a 
proton-coupled MCT.  
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Results 
Visualizing Proton-coupled Transport of MCT1 
Since transport of substrates by proton-coupled MCTs is not voltage-dependent 
and non-electrogenic, proton fluxes through MCTs may behave differently from that 
through Hv1 and ClC-5. To verify the utility of the Chapter II approach on MCTs 
transport, we transiently transfected HEK293T cells with MCT1, the most well-studied 
MCT, and incubated with azidosugar, which cells metabolize and incorporate an 
unnatural azido-group in the terminal sugar residues of the glycocalyx. After 2 days, the 
cells were labeled with an azido-reactive, fluorescent pH sensor, pH-DIBO for 30 min 
and the fluorescence change (F/F0) was monitored over time upon addition and removal 
of substrates of interest by using a gravity-perfusion system (Figure III-1A). To 
determine the perfusion rate, we decreased the external pH from 7.5 to 7.0 by using the 
perfusion system. The fluorescent signal decreased and reached to a steady state in ~ 5s, 
indicating that the external solution was completely replaced (Figure III-1B). Figure III-
1C shows the fluorescent signals in MCT1-expressing and mock transfected (control) 
cells upon addition and removal of 10 mM L-lactate in a bath solution with a constant pH 
(7.0) and a low buffer capacity (0.1 mM). In control cells, the fluorescent signals 
decreased rapidly due to endogenous MCTs and then slowly recovered as net transport 
activity slowed and protons in the media reprotonated the cell-attached pH-sensitive 
fluorophore. In contrast, the fluorescent signals in MCT1-expressing cells recovered 
faster and reversed direction, implying that the exogenous expression of MCT1 
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significantly increased proton-coupled transport of L-lactate into the cell such that proton 
efflux became thermodynamically favored (Figure III-1D, a and b). Washout of L-lactate 
resulted in a rapid efflux of protons from the cell followed by proton diffusion to the bulk 
solution (Figure III-1D, c). The transport rate for MCT1-expressing cells was 2-fold 
faster than control cells upon removal of L-lactate (Figure III-1C, inset).  
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Figure III-1. Visualization of proton fluxes in control and MCT1-expressing 
HEK293T cells. (A) Schematic representation of the gravity-perfusion system. (B) 
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SEM. (C) Fluorescence traces of MCT1-expressing (black) and control (grey) cells upon 
perfusion of 10 mM L-lactate (dash bar), inset: transport rates upon removal of L-lactate, 
n = 8; error bars denote ±SEM. (D) Schematic cartoon of proton-coupled L-lactate 
transport through MCT1 and the plasma membrane at time points indicated in (C). 
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We hypothesized that the fluorescent recovery is partially due to either the 
reprotonation of sensors from the medium (L-lactate addition) or proton diffusion to the 
bulk (L-lactate removal). To confirm this hypothesis, we performed the perfusion 
experiment under different external buffer capacities. By increasing the buffer capacity 
from 0.1 to 3 mM, the fluorescence change in both directions reduced monotonically and 
reached the peak and recovered faster (Figure III-2A), implying the buffer-dependent 
change in fluorescence is due to the competition between buffer and the glycocalyx-
attached pH sensors. 
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Partial Characterization of MCT1 by Monitoring Extracellular pH Changes      
MCT1 has a broad range of substrates. To demonstrate the utility of our approach 
on proton-coupled transport of other monocarboxylates, we replaced L-lactate with 
pyruvate, D-lactate and butyrate and measured the fluorescence changes in MCT1-
expressing and control cells (Figure III-3A, B and C). To determine relative transport 
rates, we measured the rate of proton efflux upon removal of the extracellular 
monocarboxylate, subtracted the background rate (control cells), and normalized the 
transport rates to the transport of L-lactate (Figure III-3D). The result showed that at a 
concentration of 10 mM, the MCT1 transport of L-lactate was approximately twice as 
fast as that of pyruvate, and 2.5-fold faster than that of D-lactate which is consistent with 
previous studies [85]. Because the transport of butyrate is mainly mediated by passive 
diffusion due to its high pKa [73], the transport rate of butyrate in MCT1-expressing cells 
is almost same as the background rate. 
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Figure III-3. Substrate specificity of proton-coupled transport in control and 
MCT1-expressing HEK293T cells. Fluorescence traces of MCT1-expressing (black) 
and control (grey) cells during perfusion of 10 mM (A) pyruvate, (B) D-lactate or (C) 
butyrate, n = 6 - 10; (D) Relative transport rates for different substrates. Error bars denote 
±SEM. 
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As the driving force of MCT transport is dependent on the concentration of 
substrates and pH, next we examined the effect of these both factors on the fluorescent 
signal. By increasing the concentration of substrates from 1 to 30 mM, the inward peak of 
fluorescence increased monotonically for L-lactate (Figure III-4, top panel) and reached a 
maximum at 3 mM for pyruvate (Figure III-4, middle panel). Because the transport of D-
lactate is slower than that of L-lactate and pyruvate, the fluorescent signal decreased 
slowly and did not exhibit a recovery until 10 mM (Figure III-4, bottom panel). Changing 
external pH influenced the fluorescent signal as well. In 0.1 mM HEPES buffer, 
decreasing the pH from 7.0 to 6.5 increased the inward F/F0 but decreased and slowed 
the outward F/F0 (Figure III-2B). In contrast, increasing the pH from 7.0 to 7.5 
accelerated the recovery in both inward and outward F/F0 (Figure III-2B).  
74
L-lactate, 1mM-30mM,112317,n=6
Pyvuvate, 1-30 mM, 112417, n=6
D-lactate, 1-30 mM, 112917, n-6
-0.1
0
0.1
∆F
/F
0
-0.2
0.2
0 50 100 150 200
Time (s)
-0.1
0
0.1
∆F
/F
0
-0.2
0.2
0 50 100 150 200
Time (s)
-0.1
0
0.1
∆F
/F
0
-0.2
0.2
0 50 100 150 200
Time (s)
L-lactate
Pyruvate
D-lactate
1 mM
3 mM
10 mM
30 mM
1 mM
3 mM
10 mM
30 mM
1 mM
3 mM
10 mM
30 mM
A
B
C
1 mM
-0.1
0
0.1
∆F
/F
0
-0.2
0.2 3 mM 10 mM 30 mM
-0.1
0
0.1
∆F
/F
0
-0.2
0.2 Pyruvate
-0.1
0
0.1
∆F
/F
0
-0.2
0.2
50 s
D-lactate
L-lactate
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Although MCT1 expression resulted in a faster recovery in fluorescence, we 
wanted to confirm that the fluorescence change was caused by the proton-coupled 
transport activity of MCT1. To test this, we inhibited MCT1 by adding the known MCT 
inhibitor, CHC. Compared to the control experiment (Figure III-5A), the fluorescent 
signal reduced significantly in the presence of 0.1 or 0.3 mM CHC and recovered after 
washing out CHC (Figure III-5C). However, we noticed that perfusion of CHC alone 
quenched the fluorescence (Figure III-5B). To correct for this quenching effect, we 
performed the inhibition experiment using butyrate, which does not rely on MCT1 for 
transport (Figure III-3C). After correction, the MCT1 activity was reduced by 43 ± 4% 
and 13% ± 2% at 0.3 and 0.1 mM CHC (Figure III-6C), respectively, which is in 
agreement with previous studies (Figure III-6C, dash line) [89]. 
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Figure III-5. Inhibition of MCT1 transport by CHC. (A) Representative fluorescence 
traces of a MCT1-expressing HEK293T cell when repeat perfusion of 10 mM L-lactate 
three times. (B) Representative fluorescence traces during perfusion of 0.3 mM CHC 
(black) or 10 µM phloretin (grey) only. (C) Representative fluorescence traces of a 
MCT1-expressing HEK293T cell during perfusion of 10 mM pyruvate in the absence of 
(left, black), in the presence of (middle, red) and after washing out (right, blue) 0.1 mM 
(top panel) or 0.3 mM CHC (bottom panel). 
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Identification of Hrm, a Putative MCT in Drosophila 
The gene CG11665/hrm is predicted to encode an MCT, Hrm in Drosophila. Hrm 
is required for both autophagy during steroid-triggered salivary gland cell death and 
TNF-induced non-apoptotic eye cell death (Baehrecke laboratory, unpublished data). 
However, it is still unknown whether Hrm is a proton-coupled MCT or what its substrates 
are. To determine whether Hrm mediated proton-coupled transport of monocarboxylates, 
we transiently transfected HEK293T cells with Hrm and extracellularly labeled cells with 
fluorescent pH sensors. Compared to MCT1-expressing cells, we observed similar 
fluorescent signals in cells transfected with Hrm upon extracellular perfusion of 10 mM 
pyruvate (Figure III-6A, bottom panel). The transport rate was ~ 2-fold faster than 
control cells, the same as MCT1. However, Hrm expression did not change the transport 
rate of L-lactate significantly compared to control cells (Figure III-6A, top panel).  The 
determination of relative transport rates showed that only proton-coupled pyruvate 
transport was detectable for Hrm (Figure III-6B). 
In Hrm-expressing cells, proton-coupled transport was also inhibited by CHC. At 
0.3 mM CHC, Hrm activity was reduced by 60 ± 3% whereas both overexpressed and 
endogenous MCT-1 were inhibited to a lesser extent: 43 ± 3% and 39 ± 3%, respectively 
(± SEM; n = 6 - 8 cells), indicating that the IC50 of CHC is lower for Hrm (Figure III-6C). 
Overall, these data demonstrate that Hrm is a bona fide proton-coupled monocarboxylate 
transporter that transports pyruvate faster than lactate. 
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Figure III-6. Proton-coupled transport in Hrm-expressing HEK293T cells. (A) 
Fluorescence traces were recorded during perfusion of 10 mM L-lactate (top) or pyruvate 
(bottom) in control (grey), MCT1- (black) and Hrm-expressing (red) cells, n = 8 - 10. (B) 
Relative transport rates of L-lactate and pyruvate in MCT1- and Hrm-expressing cells, n 
= 8 - 10. (C) Transport inhibition by CHC in control (grey), MCT1- (black) and Hrm-
expressing (red) cells, n = 6; the dash line indicates the reported MCT1 inhibition by 
CHC [14]. (D) Sequence alignment of human MCT1-4, 11 and Hrm; conserved key 
residues were highlighted in yellow; sequences were aligned using ClustalW multiple 
alignment in BioEdit software with default parameters. Error bars denote ±SEM. 
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Figure III-6. Proton-coupled transport in Hrm-expressing HEK293T cells. (A) 
Fluorescence traces were recorded during perfusion of 10 mM L-lactate (top) or pyruvate 
(bottom) in control (grey), MCT1- (black) and Hrm-expressing (red) cells, n = 8 - 10. (B) 
Relative transport rates of L-lactate and pyruvate in MCT1- and Hrm-expressing cells, n 
= 8 - 10. (C) Transport inhibition by CHC in control (grey), MCT1- (black) and Hrm-
expressing (red) cells, n = 6; the dash line indicates the reported MCT1 inhibition by 
CHC [14]. (D) Sequence alignment of human MCT1-4, 11 and Hrm; conserved key 
residues were highlighted in yellow; sequences were aligned using ClustalW multiple 
alignment in BioEdit software with default parameters. Error bars denote ±SEM. 
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Figure III-7. Proton-coupled transport of L-lactate and pyruvate measured by 
BCECF-AM. Cells were pre-loaded with BCECF-AM. Normalized fluorescence traces 
of control (grey), MCT1- (black) and Hrm-expressing (red) HEK293T cells during 
perfusion of 10 mM L-lactate (left) or pyruvate (right), n = 6; error bars denote ±SEM. 
80
Discussion 
Compared to Hv1 and ClC-5, proton-coupled transport by MCTs is non-
electrogenic. Previously, it has been demonstrated that extracellular addition of L-lactate 
or pyruvate to cells expressing MCT1 resulted in pHi decreasing rapidly at the beginning, 
then reaching a steady state [85,89]. Here, by covalently attaching a pH-sensitive dye to 
the cell’s glycocalyx, we observed different kinetics of pH changes at the outer surface of 
the plasma membrane: a rapid proton depletion followed by a recovery which is 
consistent with intracellular acidification, slowed MCT1 activity and proton diffusion 
from the media. 
Although there was no significant pHi gradient observed within cells, a previous 
report using pH electrodes demonstrated that pH changes at the inner face of the cell 
membrane occurred faster and more significantly compared to those in the cytoplasm in 
response to L-lactate [85]. Because our pH-DIBO was located at the cell’s glycocalyx, 
nanometers away from the transporter, it had more sensitivity than intracellular pH-
sensitive dyes. Indeed, when we measured changes in pH using BCECF-AM in cells 
expressing Hrm, we did not detect a change as significant as that using pH-DIBO (Figure 
III-7).  
Because a low buffer capacity in the bath solution was required to detect the 
fluorescent signal in response to MCT activity, the extracellular pH measurement was 
particularly sensitive to the buffer capacity changes. It is challenging to determine Km 
values for substrates by using the extracellular facing pH sensor, as monocarboxylates 
themselves contain carboxylic acid and serve as weak buffers. Furthermore, because 
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buffer capacity is dependent on the ratio of salts to acid/base, changing external pH 
influences the buffer capacity as well. Therefore, it will overestimate the roles of 
monocarboxylates and external pH on MCT activity without consideration of their effect 
on buffer capacity.  
As reported previously, exposure of cells to the known MCT inhibitor, CHC did 
not cause intracellular acidification, indicating that there is no proton transport induced 
by CHC [85]. In our experiments, however, we observed that the fluorescence decreased 
upon addition of CHC due to intermolecular PET quenching. Phloretin, another known 
MCT inhibitor with a lower Ki (~ 5 M) [91] quenched the fluorescence more 
significantly at 10 M (Figure III-5B), possibly because it has three more phenolic 
hydroxyl groups as electron donors than CHC. When studying MCT inhibitors, a 
quenching correction needs to be taken into consideration for the extracellular pH 
measurement if inhibitors are extracellular binding, and vice versa. 
In proton-coupled MCTs, there are three conserved charged residues that appear 
to be crucial for the proton-coupled transport (K38, D302/R306 in human MCT1). 
Interestingly, sequence alignment of Hrm with human proton-couple MCTs revealed that 
Hrm possesses these three residues (K74, D503 and R507) as well (Figure III-6D). 
MCT11, the closest human homolog of Hrm, performs proton-coupled transport of 
pyruvate and has been associated with type 2 diabetes [93]. However, it remains 
unknown weather MCT11 transports other substrates, such as L-lactate. Here we 
observed that Hrm transported pyruvate preferentially. No significant L-lactate transport 
was observed in Hrm-expressing cells compared to the control. One possibility is that L-
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lactate transport through Hrm is slower than that through MCT1 and was disguised by the 
endogenous MCT1. The Baehrecke group has showed that basigin, an ancillary protein 
for MCTs was required for translocation of Hrm to the plasma membrane in Drosophila. 
However, co-transfection of Hrm with either human or Drosophila basgin in HEK293T 
did not significantly increase the transport rate (data not shown).  
MCTs are expressed at specific locations of cell membranes [151,152]. For 
instance, the highest density of MCT1 in cardiomyocytes occurs in the intercalated disk 
and T-tubules regions [84]. Combining our approach with state-of-the-art imaging 
techniques will allow for detection of MCT activity over the entire landscape of a cell 
with high spatiotemporal resolution. Moreover, as extracellular pH measurement is more 
sensitive than intracellular pH measurement, this approach will support the functional 
identification of orphan MCTs and other proton-coupled transporters in mammals and 
other organisms. Given that the glycocalyces of living organisms can be engineered with 
unnatural sugars [148,149,153], visualization of proton-coupled transport events from 
cells, tissues, and model organisms is tenable by modifying metabolically labeled 
glycocalyces with pH-sensitive dyes. 
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Materials and Methods 
Chemicals 
Azidosugar (tetraacetylated N-Azidoacetyl-D-Mannosamine ) and pH-DIBO were 
synthesized as previous reported [154,155]. BCECF-AM was obtained from life 
technologies. Sodium pyruvate and sodium butyrate were obtained from Alfa Aesar. L-
lactic acid, sodium salt, 60 wt% solution in water was obtained from Acros. Sodium D-
lactate, α-Cyano-4-hydroxycinnamic acid (CHC) and phloretin were obtained from 
Sigma. 
Plasmids 
pGHJMCT1 containing rat MCT1 (rMCT1) was a gift from Sebastián Brauchi 
(Universidad Austral de Chile). CG11665/Hrm was a gift from Eric Baehrecke (Umass 
Medical School). rMCT1 and CG11665 were cloned into pcDNA3.1 for mammalian cells 
expression.  
Cell Culture, Transfections and pH-DIBO Cell Surface Labeling 
HEK293T cells were cultured in high glucose DMEM medium (Gibco) with 10% 
fetal bovine serum (Hyclone) and 100 units/mL penicillin/streptomycin (Invitrogen) at 37℃ 
in 5% CO2. The cells were seeded at 60-75% confluency in 35 mm dishes. After 24 hrs, 
cells were transiently transfected with 1 g of transporter DNA and 5 L of 
Lipofectamine 2000 (Invitrogen) in Opti-MEM (Invitrogen) for 6 hours. To visualize 
transfected cells, 0.25 g of pEGFP-C3 or mCherry was added to transfections that did 
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not contain FP-tagged transporters. After removing the transfection mixture, the cells 
were transferred to glass bottom culture dishes (MatTek) coated by fibronectin and 
incubated in media containing 50 M Ac4ManNAz for 2 days, which was replenished 
after 24 hrs.  
Extracellular pH Measurement 
After 2 days, transfected HEK293T cells were directly labeled with pH-DIBO (50 
M) in Opti-MEM at 37℃ in 5% CO2 for 30 min, then they were washed 3 times with a 
bath solution (145 mM NaCl, 5.4 mM KCl, 5 mM CaCl2 and 0.1 mM HEPES, pH 7.0). A 
35-mm chamber insert (RC-33DL, Warner) was put into the glass bottom dish to 
decrease volume. The dish was then mounted onto a Quick Exchange Platform QE-1 
(Warner) for imaging. Monocarboxylates and inhibitors were perfused in/out by using a 
gravity perfusion system at about 10 mL/min. Cells were imaged at 1 Hz using a 
CoolLED pE-4000 light source (550 nm excitation), 63 x 1.4 N.A. oil immersion 
objective, DAPI/FITC/TRITC/Cy5 filter set (CHROMA) and a Zyla sCMOS camera 
(ANDOR). Fluorescent images were collected and processed using open source software 
(micro-manager and ImageJ). F0 is the average fluorescence intensity of first five data 
points. 
Intracellular pH Measurement 
After 2 days without azidosugar treatment, the transfected cells were directly 
labeled with BCECF-AM (1 nM) in Opti-MEM at 37℃ in 5% CO2/95% air for 30 min, 
then were washed 3 times with bath solution. Cells were imaged at 1 Hz using a 
85
CoolLED pE-4000 light source (490 nm excitation), 63 x 1.4 N.A. oil immersion 
objective, DAPI/FITC/TRITC/Cy5 filter set (CHROMA) and a Zyla sCMOS camera 
(ANDOR).  
Calculations 
Transport rate: From MCT1, Hrm and mock transfected cells, the increment parts 
of fluorescence upon removal of monocarboxylates were fitted to the exponential growth 
equation. The rate constant k was treated as a transport rate. To determine a relative 
transport rate, the rate from MCT1 or Hrm was first subtracted by the background rate 
(control cells), then normalized the transport rates to the rate of MCT1 transport L-lactate. 
Remaining activity: amplitudes of inward peaks before (A0) and after (ACHC) 
adding CHC were measured. The ratio of A0 and ACHC was obtained as the remaining 
activity of transporters. The CHC quenching effect was corrected by A0/ACHC values of 
butyrate. 
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CHAPTER IV. VISUALIZATION OF MCT1 ACTIVITY IN 
CARDIOMYOCYTES USING WGA-CONJUGATED FLUORESCENT PH 
SENSORS 
Summary 
Cardiac metabolism requires transport of lactate and ketone bodies that are mainly 
mediated by MCT1. Previous studies reveal that MCT1 is densely distributed in 
intercalated disc and T-tubule regions in isolated rat cardiomyocytes. However, 
monitoring the subcellular activity of MCT1 has not been tenable with existing tools. In 
Chapter II and III we described a bioorthogonal chemistry approach to covalently attach a 
fluorescent pH sensor at the cell surface and applied it in monitoring proton fluxes 
through MCT1 in HEK293T cells. However, this approach is not applicable in 
cardiomyocytes, which cannot incorporate the unnatural sialic acid precursor into their 
glycocalyx. To address this, here we made a pH-sensitive fluorescent WGA conjugate, 
WGA-pHRho to visualize extracellular proton accumulation and depletion. Compared to 
the glycocalyx-attached pH-DIBO, WGA-pHRho has similar fluorescent signals in 
response to the changes in the extracellular proton concentration caused by proton 
channel Hv1 and omega mutant Shaker-IR R362H. Furthermore, with WGA-pHRho, we 
visualized the proton-coupled transport of MCT1 in INS-1 cells and cardiomyocytes. 
Given that WGA binds to endogenous glycoproteins at the plasma membrane, this 
straightforward approach will enable us to fluorescently visualize proton fluxes from 
most cell types. 
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Introduction 
In all animals, cardiomyocytes, which constitute the heart tissue, require a 
precisely tuned metabolism for proper function. Under normal conditions, 
cardiomyocytes take up lactate as a respiratory substrate, but under hypoxic conditions, 
they instead produce and release lactate [109]. Proton-coupled monocarboxylates (MCTs) 
play a major role in catalyzing transport of lactate into and out of cardiomyocytes. In 
particular, MCT1 is abundantly present in mammalian hearts [152]. MCT2 has been 
detected in the hamster heart [156], but not in the rat and mouse heart [157]. In rats, 
MCT4 is detected in the neonatal heart but expression decreases or is absent in the adult 
heart [158].  
To provide flexibility in lactate transport, cells often express MCTs at specific 
domains of the plasma membrane. In cardiomyocytes, MCT1 is found on the regions of 
the plasma membrane that are near capillaries and other myocytes and has the highest 
density in the intercalated disks suggesting H+/lactate fluxes between cells [159]. In 
addition, high MCT1 expression is also observed in the T-tubules which are highly 
branched invaginations of the plasma membrane in close proximity to mitochondria, 
implying that the lactate transported by MCT1 may be used for oxidative metabolism 
[159]. As MCT1 is not expressed uniformly along the plasma membrane of 
cardiomyocytes, the biochemical characteristics and functions may vary between 
different subdomains of the plasma membrane. Thus, it is of great interest to monitor 
MCT1 activity spatiotemporally over the entire plasma membrane in cardiomyocytes. 
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Currently, because lactate fluxes through MCTs are associated with proton 
transport, intracellular fluorescent pH sensors such as BCECF-AM have been widely 
used to monitor the transport activity of proton-coupled MCTs [73]. Although this 
approach enables the transport detection in real-time, it is unable to distinguish MCT 
activity at different plasma membrane domains. In contrast, extracellularly attached 
fluorescent pH sensors will allow for monitoring MCTs activities at different regions of 
the plasma membrane. In Chapter II and III, we described a bioorthogonal chemistry 
approach to target a pH-sensitive dye to the cell’s glycocalyx and applied it in real-time 
visualization of extracellular proton accumulation and deletion in HEK293T cells 
expressing MCT1. However, we found that this approach is not tenable in some cells, 
such as INS-1 cells and cardiomyocytes that do not incorporate the unnatural sialic acid 
precursor into their glycocalyx. Therefore, we sought to develop an approach that was 
more universally applicable. 
Wheat germ agglutinin (WGA) binds to N-acetyl-glucosamine and sialic acid at 
the cell’s glycocalyx [160] and has been routinely used to demarcate the plasma 
membrane of live and fixed cells [161]. A WGA-fluorescein conjugate has been used to 
approximate pH changes in the extracellular region of single melanoma cells [123], 
raising the possibility that pH-sensitive WGA-conjugates may enable the visualization of 
proton fluxes from ion channels, transporters and omega mutants in the extracellular 
nanodomains.  
Herein we described the synthesis of WGA-pHRho (Figure IV-1A), a pH 
sensitive, red fluorescent WGA conjugate that binds to cell’s glycocalyx (Figure IV-1B). 
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Despite visual signs of endocytosis, proton fluxes from proton channel Hv1 and omega 
mutant Shaker-IR R362H/W434F can be detected within 3 hrs after labeling with the 
localized WGA-pHRho. Since many ion channels are glycosylated, and WGA is able to 
bind to these modifications, we confirmed that WGA labeling did not appreciably alter 
the activities of glycosylated or non-glycosylated ion channels as measured by the current 
density and voltage-activation. Compared to commercially-available WGA-fluorescein, 
WGA-pHRho is photostable, increases fluorescence upon protonation, and has a pKa of ~ 
7 which is well matched for extracellular pH measurements. Furthermore, with WGA-
pHRho, we monitored the transport activity of MCT1 on the entire plasma membrane of 
INS-cells and cardiomyocytes. Given that any small-molecule fluorescent sensor can be 
conjugated to WGA and all cells have terminal sugars for WGA binding, this 
straightforward approach will enable physiologists to visualize any transport events at the 
plasma membrane from most cell types. 
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Figure IV-1. The synthesis of WGA conjugates to visualize plasma membrane 
proton fluxes. (A) Scheme for the synthesis of WGA-pHRho. (B) Cells expressing ion 
channels or transporters are labeled with WGA-pHRho to detect proton fluxes by using 
patch clamp fluorometry. (C) pH standard curves of WGA-pHRho in solution (top, n = 6) 
or attached to the plasma membrane of CHO cells (bottom, n = 22). Buffer concentrations 
are 10 mM; ∆F/F0 at pH 7.5 was defined as 0; error bars are ±SEM. 
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Results 
Synthesis and characterization of a pH sensitive WGA conjugate, WGA-pHRho 
Compared to small-molecule dyes with molecular weight <1000, WGA exists 
mostly as a heterodimer of 38,000 daltons in solution and is cationic at physiological pH 
[161]. In order to confirm that WGA labeling would not alter the activity of membrane 
transport proteins, we recorded families of currents from cells transiently transfected with 
voltage-gated proton channels Hv1 or Shaker-IR potassium channels before and after 
treatment with WGA (Figure IV-2A). Hv1 cannot be N- or O-glycosylated as it doesn’t 
contain any extracellular serine or threonine residues [162].  In contrast, Shaker-IR 
contains two N-linked glycosylation sites in the S1-S2 loop of the voltage-sensor [163]. 
After WGA treatment, the current density of Hv1 was reduced by ~ 30% at 60 mV 
depolarization, but that of Shaker-IR did not change significantly. In contrast, tail current 
analysis showed that WGA treatment did not significantly affect the voltage-activation of 
Hv1; a small, but statistically insignificant shift was measured for Shaker-IR (Figure IV-
2B). All these results indicate that unglycosylated and glycosylated ion channels were 
negligibly affected by WGA binding. 
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Figure IV-2. Effects of WGA-binding on the activities of unglycosylated and 
glycosylated ion channels. (A) Voltage-clamp current traces of CHO cells expressing 
Hv1 (top panel) and Shaker-IR (bottom panel) before (black) and after WGA treatment 
(red). Cells were held at – 80 mV. Currents were elicited from – 50 mV to 100 mV for 
Hv1 (scale bars: 1 nA, 100 ms), and from – 70 to 60 mV for Shaker-IR (scale bars: 2 nA, 
50 ms) in 20-mV increments. Middle panel shows a comparison of currents before and 
after WGA treatment at 60 mV depolarization. (B) G-V curves of Hv1 (triangles) and 
Shaker-IR (circles) before (solid) and after WGA treatment (open). V0.5 = 68.32 ± 6.38 
mV (n = 8, solid triangles), 67.40 ± 7.82 mV (n = 9, open triangles), – 18.01 ± 1.15 mV 
(n = 5, solid circles) and – 10.39 ± 1.37 (n = 6, open circles); error bars are ±SEM. 
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Next, we determined whether pH-sensitive WGA conjugates would effectively 
report on proton accumulation and depletion on the extracellular side of the plasma 
membrane. We made a red fluorescent, pH sensitive WGA-conjugate (WGA-pHRho) by 
activating the carboxylic acid of pHRho with dicyclohexylcarbodiimide (DCC) and N-
hydroxysuccinimide (NHS) (Figure IV-1A), incubating it with WGA for 2 hrs, and 
separating out the unreacted dye with a gravity-fed size exclusion column. Although 
attaching WGA-pHRho to the cell surface decreased the pH sensitivity, the F/F0 and pH 
exhibited a linear relationship in the range between 6.0 and 8.5, indicating conjugation of 
the small molecule pH-sensitive fluorophore to WGA did not change the apparent pKa of 
6.9 [120] (Figure IV-1C). To visualize proton efflux with WGA-pHRho, Chinese hamster 
ovary (CHO) cells were treated with 50 g/mL WGA-pHRho for 10 min and the current 
and fluorescence were measured using patch-clamp fluorometry in a bath solution with a 
low buffer capacity (0.1 mM) (Figure IV-1B). Figure IV-3A (left panel) shows families 
of currents and fluorescent signals from a CHO cell expressing a C-terminally GFP-
tagged, human voltage-gated proton channel (hHv1). Under low buffer conditions, 
voltage-activation of Hv1 channels resulted in small currents (~ 200 pA at 100 mV) that 
reached steady state faster with stronger depolarizations. Simultaneous imaging of the 
cell’s fluorescence at 10 Hz showed that the change in fluorescence was similar to 
voltage-dependence currents of Hv1; however, the rate to reach steady state was slower 
as it corresponds to proton accumulation at the cell surface rather than Hv1 channel 
gating. This distinction between channel gating and proton accumulation (or depletion) 
was clearly evident upon Hv1 deactivation at – 80 mV: no current remained after 300 ms 
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whereas it required seconds for the fluorescent signal to fully decay. As observed in 
Chapter II, the fluorescent decay has two time-constants: the fast component 
corresponding to protons rushing into the cell before Hv1 channel closing and a slow 
component corresponding to proton diffusion into the bulk solution. F snapshots before, 
during and after a 100-mV test pulse highlight the kinetic differences in proton 
accumulation and depletion at the cell surface (Figure IV-3B, left panel). 
  
95
Hv1
2%， 2s
100 pA
a
b
c
I
∆F/F0
Shaker-IR R362H/W434F
a’
b’
c’
1000
200
600
10 µm
a b c a’ b’ c’
14121086420
Time (s ) Sw eep:1 V is ib le :1 of  1
IN
 0
(n
A
)
- 0 .15
-0.1
-0.05
0
0.05
0.1
0.15
2.896 s
-0.0118 nA
2
8.689 s
0.0012 nA
3
2.896 s
0.0006 nA
4
2.896 s
0.0115 nA
1
Control
A
B
∆F
Hv1 Shaker-IR R362H/W434F
W
G
A-
pH
R
ho
Figure IV-3. Visualization of proton accumulation and depletion at the cell surface 
with WGA-pHRho. (A) Voltage-clamp fluorometry traces from CHO cells transfected 
with Hv1 (left panel), Shaker-IR R362H/W434F (middle panel) or empty vector (control, 
right panel). Hv1-expressing and control cells were held at – 80 mV. Currents and 
fluorescence were elicited from 4-s command voltages from 0 to 100 mV in 20-mV 
increments for Hv1, and at 100 mV depolarization for control cells. Shaker-IR 
R362H/W434F-expressing cells were held at 30 mV and currents and fluorescence were 
elicited from 4-s command voltages from – 120 to – 20 mV in 20-mV increments. (B) ∆F 
snapshots of WGA-pHRho fluorescence at time points indicated in (A). pHo/pHi = 7.5/6.0 
for Hv1 and control, and 6.0/7.5 for Shaker-IR R362H/W434F; 0.1 mM HEPES in the 
bath solution. Voltage-clamp fluorometry scale bars represent 100 pA, 2% ∆F/F0 and 2s; 
the scale bar in images represent 10 µm. 
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To visualize proton depletion, we set up an inward proton gradient and used a 
potassium pore-blocked (W434F) Shaker-IR R362H mutant that creates an omega proton 
pore upon hyperpolarization [32]. The fluorescent signal mirrored the current: it became 
dimmer and reached steady state upon hyperpolarization, and then recovered with 
biexponential kinetics when the cell was returned to the 30-mV holding potential (Figure 
IV-3A, middle panel). F snapshots before, during and after a – 120 mV test pulse 
showed an inverse fluorescent change at the cell surface compared to Hv1 (Figure IV-3B, 
right panel). In empty-vector control cells, no fluorescence change was observed, 
indicating that all fluorescence changes were due to proton fluxes from Hv1 or Shaker-IR 
R362H/W434F mutant (Figure IV-3A, right panel).  
All above images were collected within 1 hr of labeling when the majority of the 
WGA-pHRho appeared to be on the cell surface as evidenced by the circular labeling 
pattern (Figure IV-4A). However, we observed that bright puncta became evident 1 hr 
after labeling, and visually overwhelming at 3 hrs, implying that WGA-pHRho was 
internalized and localized in low pH internal compartments (endosomes and lysosomes). 
To determine whether this internalization would affect the fluorescent signals, we 
recorded the current and fluorescence until 4 hrs after labeling. The fluorescent signal 
still had a response to the current (Figure IV-4B), but the ratio of F/F0 over the current 
was decreased ~ 20% after 1 h, and ~ 50% after 3 hrs post-labeling, implying that some 
of the extracellular pH sensors were internalized (Figure IV-4C). Although the signal 
intensity decreases overtime, this approach is viable for longer timepoints. In addition, 
the data in the latter time points likely favored cells with less internalized WGA-pHRho, 
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because it became noticeably harder over time to make and maintain a gigaohm seal in 
the whole cell configuration. For experimental ease, it was experimentally prudent to 
image and record immediately after labeling. 
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Figure IV-4. Internalization of WGA-pHRho in CHO cells. (A) Fluorescent images of 
CHO cells were collected at 0, 1, 2 and 3 hours after WGA-pHRho labeling, the scale bar 
represents 10 µm. (B) An exemplar of current-fluorescence traces from a Hv1-expressing 
cell at 3 hrs after labeling, scale bars represent 100 pA, 1% ∆F/F0 and 2 s. The cell was 
held at – 80 mV, and currents and fluorescence were elicited from 4-s command voltages 
from 0 to 100 mV in 20-mV increments. (C) A bar graph shows the ratio of ∆F/F0 and 
current (I) in 1, 2, 3, 4 hours after labeling, n = 5; error bars represent ±SEM.  
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WGA-fluorescein is commercially available and has been used to approximate pH 
changes at the surface of single melanoma cells [123]. To make a fair comparison with 
WGA-pHRho, we made WGA-fluorescein by reacting FITC with WGA and removing 
the unreacted fluorophore with a gravity-fed size exclusion column. Compared to WGA-
pHRho (Figure IV-3A), homemade WGA-fluorescein yielded the mirror opposite 
response to extracellular proton accumulation (Hv1) and depletion (Shaker-IR 
R362H/W434F) with approximately the same current-F/F0 relationship (Figure IV-5A 
and C). As expected, photobleaching was problematic with WGA-fluorescein (Figure IV-
5B), especially for extracellular proton accumulation where the fluorescent signal was 
also quenched by protons. There was no noticeable difference between commercially-
available and homemade WGA-fluorescein. Thus, for extracellular proton depletion near 
fluorescein’s pKa of 6.4, commercially-available WGA-fluorescein was a satisfactory 
reagent when photobleaching could be reliably corrected. 
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Figure IV-5. Visualization of proton fluxes with WGA-fluorescein. (A) Voltage-
clamp fluorometry traces from CHO cells transfected with Hv1 (left panel), Shaker-IR 
R362H/W434F (right panel). The Hv1-expressing cell was held at – 80 mV, and currents 
and fluorescence were elicited from 4-s command voltages from 0 to 100 mV in 20-mV 
increments. The Shaker-IR R362H/W434F-expressing cell was held at 30 mV, and 
currents and fluorescence were elicited from 4-s command voltages from – 120 to – 20 
mV in 20-mV increments. (B) Fluorescence signals without photobleaching correction of 
WGA-pHRho (red) and WGA-fluorescein (green) during voltage-clamp experiment in 
Hv1-expressing CHO cells; cells were held at – 80 mV, and currents and fluorescence 
were elicited from 4-s command voltages from 0 to 100 mV in 20-mV increments. (C) 
∆F/F0-current curves show the current sensitivity of WGA-pHRho (solid circle, red) and 
WGA-fluorescein (open square, green). pHo/pHi = 7.5/6.0 for Hv1, and 6.0/7.5 for 
Shaker-IR R362H/W434F; 0.1 mM HEPES in the bath solution. Scale bars represent 200 
pA, 2% ∆F/F0 and 2 s. 
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Visualization of proton-coupled transport of MCT1  
INS-1 cells, a pancreatic β cell line, have very low endogenous MCT1 levels and 
have no MCT2 or MCT4 [90,164]. We attempted to label INS-1 cells with azidosugar 
and pH-DIBO to monitor proton fluxes from MCT1 but they also cannot use the 
unnatural sialic acid precursor. To determine whether WGA-pHRho can bind to the 
plasma membrane of INS-cells and detect proton fluxes from MCTs, we transiently 
transfected MCT1 into INS-1 cells. After 48 hrs, cells were treated with 50 g/mL WGA-
pHRho for 10 min and the fluorescence was recorded during extracellular perfusion of 10 
mM L-lactate or pyruvate in a bath solution with a constant pH (7.0) and a low buffer 
capacity (0.1 mM) (Figure IV-6A and B). Upon perfusing L-lactate, the fluorescence of 
control cells had a small increase initially and then decreased slowly. In contrast, the 
fluorescence of MCT1-expressing cells decreased rapidly, reaching peak in 5 sec and 
then recovered and reversed the direction indicating the exogenous MCT1 significantly 
increased proton-coupled transport of L-lactate into the cell. Washout of L-lactate 
resulted in a rapid efflux of protons from the cell followed by proton diffusion to the bulk. 
A similar result was obtained during perfusion of 10 mM pyruvate, another 
physiologically important substrate for MCT1 (Figure IV-6B). 
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Figure IV-6. Visualization of proton-coupled transport of L-lactate and pyruvate in 
MCT1-expressing INS-1 cells. Fluorescence traces of MCT1-expressing (black) and 
control (grey) cells upon perfusion of 10 mM (A) L-lactate or (B) pyruvate, n = 6; error 
bars denote ±SEM. 
Control
MCT1
Control
MCT1
103
MCT1 is critical for the oxidative capacities of cardiomyocytes and is more 
expressed in intercalated disc and T-tubule regions. Visualizing the transport activity of 
MCT1 in cardiomyocytes spatiotemporally is of high interest. Similar with INS-1 cells, 
we found that cardiomyocytes cannot use the unnatural sialic acid precursor either. To 
determine whether we can label cardiomyocytes with WGA-pHRho and monitor the 
transport activity of endogenous MCT1, we isolated cardiomyocytes from rat hearts and 
treated them with WGA-pHRho for 30 min after 2 hrs culture. Fluorescent images show 
that WGA-pHRho was distributed at the sarcolemma and T-tubule regions in 
cardiomyocytes after labeling (Figure IV-7A). During L-lactate perfusion, we observed a 
rapid decrease followed by a recovery in fluorescence (Figure IV-7B). However, 
compared to the fluorescent signals in HEK293T (Chapter III) and INS-1 cells expressing 
MCT1, the recovery did not reverse direction in cardiomyocytes. Perfusion of D-lactate 
on the same cell resulted in a smaller fluorescent change and a slower recovery in 
fluorescence, demonstrating that the transport rate of D-lactate is lower than L-lactate. To 
confirm the role of MCT1 on the fluorescence change, we pre-treated cardiomyocytes 
with 50 nM AR-C155858, a specific MCT1 inhibitor binding to MCT1 intracellularly [92] 
for 30 min. After AR-C155858 treatment, perfusion of L-lactate on the same cell caused 
a much slower and smaller decrease in fluorescence, and no recovery was observed. As 
adult rat cardiomyocytes only express MCT1 and have no other proton-coupled MCTs, 
this fluorescence change is mainly due to passive diffusion of lactic acid. 
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Figure IV-7. Visualization of MCT1 transport in cardiomyocytes. (A) The left 
fluorescent image shows WGA-pHRho distribution in cardiomyocytes after labeling. The 
schematic cartoon on the right shows MCT1 transport in sarcolemma and T-tubule 
regions in cardiomyocytes; the scale bar represents 10 µm. (B) Fluorescence traces of a 
cardiomyocyte upon perfusion of 10 mM L-lactate (black) and pyruvate (red) 
successively. (C) Fluorescence traces of a cardiomyocyte upon perfusion of 10 mM L-
lactate before (black) and after (red) 50 µM AR-C155858 treatment. 
105
Discussion 
In Chapter II and III, we described an approach to covalently attach pH-DIBO to 
the cell’s glycocalyx that was engineered by an azidosugar. However, not all cell types 
can utilize this unnatural sialic acid precursor. For instance, we did not observe pH-DIBO 
labeling in INS-1 cells or cardiomyocytes after 48 hrs incubation with azido-sugar. One 
advantage of WGA-conjugates is that WGA binds to mammalian glycocalyces without 
the need of an unnatural sialic acid precursor. 
By labeling cells with pH-sensitive, fluorescent WGA conjugates, we observed 
proton accumulation and depletion at the plasma membrane resulting from proton 
channel Hv1, omega mutant Shaker-IR R362H/W434F and MCT1. Although the 
molecular weight of a WGA-conjugate is ~ 40-fold higher than that of pH-DIBO used in 
Chapter II and III, the fluorescent signals corresponding to proton fluxes are both similar. 
Previous studies showed that the terminal sialic acids in voltage-gated cation channels 
modulate channel gating and function [165,166]. Even though our approach utilized 
WGA-sialic acid binding, we did not observe any significant activity changes in either 
unglycosylated or glycosylated membrane transport proteins.  
Compared to the labeling time for pH-DIBO (30 min), WGA effectively labeled 
cells in only 10 min. Such fast labeling reduces background signal caused by endocytosis; 
the cells after labeling exhibit a bright circular fluorescence and have very few puncta 
even after 1 hr of labeling. Although a subpopulation of sensors is internalized over time, 
it doesn’t affect the fluorescent signal significantly, as the luminally facing fluorescent 
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sensors are unresponsive to the transport events occurring at the cell surface and there are 
enough uninternalized sensors to detect extracellular pH changes 3 hrs after labeling.  
Perfusion of L-lactate or pyruvate in mock-transfected HEK293T cells caused the 
fluorescence signal to decrease rapidly, followed by a slow and partial recovery (Chapter 
III). Surprisingly, when compared to HEK293T cells we observed slower and smaller 
changes in fluorescence when perfusing L-lactate or pyruvate in mock-transfected INS-1 
cells. Additionally, we did not observe a recovery of fluorescence, indicating that INS-1 
cells have much lower endogenous MCT activity than HEK293T cells, making them an 
appropriate model system for functional characterization of MCTs in mammalian cells.  
MCT1 is abundantly expressed in cardiomyocytes and is crucial for cardiac 
physiology. Here we labeled cardiomyocytes with WGA-pHRho and monitored the 
MCT1 activity in real-time. During perfusion of L-lactate, the fluorescent signal is 
similar to that in HEK293T and INS-1 cells. Interestingly, in cardiomyocytes we noted 
that the fluorescence recovery did not reverse the direction, which may be due to the 
large volume of the cell. According to immunofluorescence staining studies, MCT1 is 
densely localized in T-tubule regions that are near mitochondria, implying that MCT1 
promotes the delivery of lactate to the oxidation site [167]. Given that WGA-pHRho can 
label sarcolemma and T-tubules in cardiomyocytes, our approach will allow for 
monitoring MCT1 activity in these specific regions with high spatiotemporal resolution 
when combined with the state-of-the-art imaging.  
Proton fluxes also exist in other proton-coupled transporters and are involved in a 
wide range of cellular processes. For instance, Na+/H+ exchanger 1, NHE1 is implicated 
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in regulation of transepithelial transport, cell volume, cell death/survival balance and cell 
motility [168]. Therefore, pH sensitive, fluorescent WGA conjugates that work with a 
majority of cell types have broad utility. Moreover, when combined with a pH-insensitive 
WGA conjugate, a pseudo-ratiometric pH sensor will allow for calibrated pH 
determinations. Given a wide variety of ion- and metabolite-sensitive small-molecule 
dyes, WGA-conjugates can be used for studying any transport events at the plasma 
membrane. 
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Materials and Methods 
Materials 
WGA was obtained from Vector Laboratories. FITC and commercial WGA-
fluorescein were obtained from Invitrogen. Sodium pyruvate was obtained from Alfa 
Aesar. L-lactic acid, sodium salt, 60 wt% solution in water was obtained from Acros. 
Sodium D-lactate was obtained from Sigma. AR-C155858 was obtained from Torcis. 
Synthesis Procedures   
pHRho (7) 
 
Compound 3 (50 mg, 0.06 mmol) synthesized in Chapter II was dissolved in 2 mL 
4M HCl. After being stirred at r.t. for 4 h, the solvents were evaporated under reduced 
pressure. The residue was purified by HPLC.  
WGA Conjugates 
pHRho-COOH (1.5 mg, 2.1 µmol) was reacted with dicydohexylcarbodiimide 
(DCC: 4.0 mg, 19.8 µmol) in anhydrous N, N-dimethylformamide (DMF; 0.75 mL) at r.t. 
for 15 min, and then N-hydorxysuccinimide (NHS; 3 mg, 17.4 µmol) was added and 
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stirred at r.t. 2 hrs [120]. In 200 l WGA solution (1 mg WGA at 5mg/ml, in 0.1 M 
sodium bicarbonate pH 8.3) containing 15 mg N-acetylglucossamine (0.14 µmol), the 
activated pHRho-COOH was added at a dye-to-protein molar ratio of 5. Reaction mixture 
was stirred at r.t. for 2 hrs, and the reaction was terminated by hydroxylamine to a final 
concentration of 0.1 M. For the synthesis of WGA-fluorescein, FITC stock solution was 
prepared at 10 mg/mL in DMF immediately before starting the reaction, and 0.26 µmol 
FITC dye was added to WGA solution with N-acetylglucossamine (pH 9.0). The final 
molar ratio of dye: protein was 10:1. WGA-conjugates were separated from free 
unreacted reagent by gel filtration on a Sephadex G-25 Fine (20~50 mm) column 
equilibrated by PBS and were lyophilized down to a powder (ref. patent 5846737, Kang). 
The degree of labeling (D.O.L.) was calculated using the following equation: the 
absorbance of WGA-conjugates was measured at 280 nm (A280) and the λmax (Amax).  
DOL =
A 𝑚𝑎𝑥 × MW
[WGA] × 𝜀 𝑑𝑦𝑒
   
where MW= the molecular weight of WGA, εdye = the extinction coefficient of 
dye at its absorbance maximum, and the WGA protein concentration is in mg/mL. 
Molecular Biology 
Plasmids containing human Hv1, Shaker-IR R362H/W434F mutant and rat MCT1 
were gifts from David Clapham (Harvard Medical School), Baron Chanda (University of 
Wisconsin–Madison) and Sebastián Brauchi (Universidad Austral de Chile), respectively. 
All DNA was cloned into pcDNA3.1 for mammalian cells expression. 
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Cell Culture and Transfections 
Chinese Hamster Ovary-K1 (CHO) cells were cultured in F-12K nutrient mixture 
(Gibco); INS-1 cells were cultured in RPMI medium 1640 (Gibco). All media was 
supplemented with 10% fetal bovine serum (Hyclone) and 100 units/mL 
penicillin/streptomycin (Gibco). RPMI medium 1640 was additionally supplemented 
with 1 mM sodium pyruvate and 55 M 2-Mercaptoethanol (BME). Cells were plated at 
60 ~ 75% confluency in 35 mm dishes. After 24 h incubation, cells were transiently 
transfected with 1 g of ion channel or transporter DNA and 5 L of Lipofectamine 2000 
(Invitrogen) in Opti-MEM (Invitrogen).  To visualize transfected cells, 0.25 g of 
pEGFP-C3 or mcherry was added to transfections that did not contain GFP- or mcherry-
tagged channels/transporters.   
Isolation and Culture of Cardiomyocytes 
Sprague–Dawley rat heart cells were isolated by enzymatic digestion using a 
Langendorff perfusion apparatus. The heart was perfused with oxygenated solutions at 
37℃:  (1) Ca2+ free buffer pH7.4 and contained (mM) NaCl 118, KCl 4.8, HEPES 25, 
K2HPO4 1.25, MgSO4 1.25, and Glucose 10 for 5 min. (2) Liberase TM research grade 
enzyme blend at 34ug/ml in Ca2+ free buffer for 15min. (3) Finally, a high K+ KB 
solution was used to wash out the enzyme, and single cells were stored at room 
temperature in KB until plated onto the glass bottom dishes with 5% serum Medium 199 
and incubated at 37℃ with 5% CO2. (4) After 2hrs, cells were ready for WGA labeling. 
Cell Surface Labeling  
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Transfected CHO and INS-1 cells were trypsinized and seeded on 35 mm glass 
bottom culture dishes (MarTek) for 2 hrs before labeling. All cells were rinsed with 
HBSS three times and then labeled with WGA-pHRho or WGA-fluorescein (50 g/mL) 
in HBSS at r.t. for 10 min (CHO and INS-1 cells) or 30 min (cardiomyocytes). After 
labeling, cells were rinsed with recording or perfusion solution three times. 
Whole Cell Patch Clamp Fluorometry 
Transfected cells were identified using an inverted light microscope (Axiovert 40 
CFL; Carl Zeiss, Inc.) and the currents were recorded in the whole cell patch 
configuration at room temperature (24 ± 2°C) using a glass electrode (pipette resistance: 
2.5 – 3.5 MΩ) filled with (in mM): 126 NaCl, 2 MgSO4, 0.5 CaCl2, 5 EGTA 4 K2-ATP, 
0.4 GTP and 25 buffer (HEPES for pH = 7.5 and 7.0, MES for pH = 6.0) with NaOH; 
bath solution contained (in mM): 145 KCl, 5.4 KCl, 5 CaCl2, 0.1 buffer (TAPS for pH = 
8.0, HEPES for pH = 7.5 and 7.0, Bis-Tris for pH = 6.5, MES for pH = 6.0) with KOH.  
Cells were imaged at 10 Hz using a CoolLED pE-4000 light source, 63 x 1.4 N.A. oil 
immersion objective, and a Zyla sCMOS camera (ANDOR).  The patch clamp (Axopatch 
200B), light source, and camera were controlled with Clampex 10.5 (Molecular Devices); 
fluorescent images were collected (10 Hz) and processed using open source software 
(micro-manager and ImageJ). F0 is the average fluorescence intensity of first five data 
points. 
Extracellular pH Measurement with Gravity Perfusion 
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A 35-mm chamber insert (RC-33DL, Warner) was put into the glass bottom dish 
containing HEK293T cells or cardiomyocytes in order to decrease the bath volume. The 
dish was then mounted onto a Quick Exchange Platform QE-1 (Warner) for imaging. 
Monocarboxylates and inhibitors were perfused in/out by using a gravity perfusion 
system at ~10 mL/min. Cells were imaged at 1 Hz using a CoolLED pE-4000 light source 
(550 nm excitation), 63 x 1.4 N.A. oil immersion objective, DAPI/FITC/TRITC/Cy5 
filter set (CHROMA) and a Zyla sCMOS camera (ANDOR). Fluorescent images were 
collected and processed using open source software (micro-manager and ImageJ). F0 is 
the average fluorescence intensity of first five data points. 
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CHAPTER V. DISCUSSION AND FUTURE DIRECTIONS 
Proton fluxes at the plasma membrane are created not only by proton channels 
and omega mutants, but also by various proton-coupled transporters. They play a crucial 
role in regulating intra- and extra-cellular pH and facilitating co-transport of other ions 
and metabolites. Therefore, chemical tools which visualize proton fluxes specifically at 
the plasma membrane have broad utility. Although intracellular pH measurements have 
been performed using both genetically-encoded and small-molecule fluorescent pH 
sensors, these approaches underestimate the density and kinetics of plasma membrane 
proton fluxes and provide little spatial information. Targeting fluorescent pH sensors to 
the extracellular surface has become of great interest, because it will allow for monitoring 
the local pH changes that more closely mirror proton fluxes.  
Genetically-encoded and small-molecule fluorescent pH sensors have both been 
targeted to membrane proteins for studying endocytosis and exocytosis [112,122]. 
However, proton flux detection using this approach is dependent on the expression level 
of the membrane proteins and its proximity to the transporter of interest. Moreover, it is 
difficult to target pH sensors directly to the extracellular side of membrane transporting 
proteins which do not have extracellular termini such as Hv1, ClC-5, Shaker-IR and 
MCT1. 
Besides membrane proteins, lipids and carbohydrates at the plasma membrane 
also can be used as targets for small-molecule fluorescent pH sensor labeling. Compared 
to pH sensors conjugated to lipids which have high flexibility [169], in my thesis we 
hypothesized that conjugation of sensors to the cell’s glycocalyx would be more stable 
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and would result in a uniform and dense coating of fluorescent pH sensors at the cell 
surface to enable visualization of extracellular proton fluxes.  
In Chapter II, we described a bioorthogonal chemistry approach to covalently 
attach a small molecule, fluorescent pH sensor to the cell’s glycocalyx. Using this 
approach, we were able to monitor the changes in proton concentration at the plasma 
membrane resulting from the voltage-gated proton channel Hv1, the voltage-gated H+/Cl- 
antiporter ClC-5 and mutants of the Shaker channel R362H and R371H that produce 
omega current. Our results provide direct evidence of extracellular proton accumulation 
and deletion caused by proton efflux and influx, respectively. These results, combined 
with a recent study that showed proton depletion on the intracellular side of Hv1 channels 
[39], suggest that the local proton driving force could be vastly different from the bulk 
proton gradient.  
It is notable that proton dynamics at the extracellular surface are different from 
those in bulk solution because of microenvironment complexity. For example, 
experimental and theoretical studies demonstrated that lipid head groups can act as a 
proton-collecting antenna accelerating proton uptake from the bulk solution to 
membrane-anchored proton acceptors [144,170]. Here we observed proton wavefronts 
emanating from one cell altering the local pH environment of nearby cells. Combining 
our approach with high-resolution spatiotemporal imaging will allow for monitoring 
proton diffusion along the cell surface and into the bulk solution. This will answer the 
question as to whether protons rapidly circumscribe a living cell before diffusing into the 
bulk solution.  
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Extracellular protons can not only modulate the activity of some membrane 
proteins, such as voltage-gated calcium channels [171,172], N-methyl-D-aspartate 
(NMDA) [173,174] and g-amino butyric acid (GABA) receptors [175,176], but also act 
as an agonist for acid-sensing ion channels (ASICs) which are voltage-insensitive sodium 
channels and involved in pathological states such as retinal damage, seizures, and 
ischemic brain injury [177,178]. Moreover, protons are important neurotransmitters. 
They can mediate muscle contraction in Caenorhabditis elegans [179], regulate synaptic 
plasticity in the lateral amygdala [112], as well as convey excitatory stimuli from inner 
ear type I vestibular hair cells to postsynaptic calyx nerve terminals [113]. By using our 
approach, monitoring the proton wavefronts will shed light on how the emanated protons 
modulate or activate nearby membrane proteins or downstream signaling. One limitation 
of our approach is that factors such as excitation source fluctuations and sensor 
concentration would affect the fluorescent intensity of pH-DIBO, which is a single-
emission sensor, and make it difficult to measure extracellular pH accurately. To address 
this, it is required to develop an azido-reactive, ratiometric pH sensor. 
In Chapter III, we applied this approach to detect the activity of MCT1 which 
mediates non-electrogenic, proton-coupled transport of monocarboxylates such as lactate 
and pyruvate. Compared to intracellular pH measurement (BCECF-AM) that shows 
intracellular acidification upon addition of L-lactate or pyruvate in MCT1-expressing 
cells, we observed proton depletion followed by a recovery at the cell surface due to 
proton influx and sensor re-protonation. Furthermore, by using this approach we 
identified a putative MCT, Hrm in Drosophila as a proton coupled MCT that 
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preferentially transports pyruvate. Our results clearly demonstrate that pH measurement 
at the cell surface is more sensitive than monitoring intracellular pH changes.  
MCTs belong to solute carrier proteins (SLCs) that are essential for nutrient 
uptake and waste removal in cells. A quarter of the more than 400 SLC genes are 
associated with human diseases and are important drug targets [180]. However, compared 
to other membrane proteins, SLCs are the most neglected group of genes and many of 
them have not been functionally identified yet. The transport events in some SLCs often 
induce changes in the extracellular pH, such as H+/oligopeptide cotransporter, H+/Na+ 
exchanger, Na+/HCO3
- cotransporter and Cl-/HCO3
- exchanger. Glycocalyx-attached pH 
sensors not only provide a tool for functional identification of proton-involved SLCs, but 
also can be used for real-time and spatiotemporal measurements of SLC transport to help 
us better understand their physiological and pathophysiological roles.  
Because glycan engineering has been applied in various mammalian cell lines 
[139,140,181], tissues [182] and living organisms [126,149,183,184], we expected that 
the Chapter II approach can be broadly applicable in vitro and in vivo. However, not all 
cell types can incorporate the unnatural sugar into their glycocalyx. For example, INS-1 
cells, which are one of pancreatic beta cell lines, and cardiac myocytes did not be labeled 
successfully by using azidosugar and pH-DIBO (data not shown). It is possibly due to the 
low permissivity of the sialic acid biosynthetic pathway or the slow metabolism of the 
sialic acid in these cell types. In addition, in vivo delivery of the unnatural sugar and the 
small-molecule dye to the target of interest is difficulty in some cases. Although pH-
DIBO has a certain solubility in water, its two large hydrophobic regions slow the 
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diffusion in aqueous phase. For example, we attempted to inject pH-DIBO into the 
pseudocoelomic space of C-elegans, but the fluorescent signal was only observed in the 
injection site and not in coelomocytes indicating pH-DIBO did not diffuse to the 
pseudocoelomic fluid (data not shown). Another challenge is the in vivo delivery of 
azidosugar, especially in the brain because of its inability to cross the blood-brain barrier 
(BBB) and a further modification, e.g. liposome encapsulation, was required in 
azidosugar for facilitating the delivery [148]. 
Since not all cell types are amenable to surface glycan engineering, we sought to 
develop an approach that would work with a majority of cell types. In Chapter IV, we 
conjugated pH sensors to WGA that binds to endogenous terminal sugar residues at the 
cell surface. Despite visual signs of endocytosis, the fluorescent signals of the pH-
sensitive, WGA-pHRho conjugate are similar to that of pH-DIBO in response to proton 
efflux and influx from Hv1 and Shaker-IR R362H/W434F. We successfully used WGA-
pHRho to label the plasma membrane of INS-1 cells and rat cardiomyocytes which 
cannot incorporate the unnatural sialic acid precursor into their glycocalyx and monitored 
proton fluxes from MCT1 in these cells. This straightforward approach and the detailed 
procedures of WGA conjugation and cell surface labeling will enable physiologists to 
employ these reagents to visualize plasma membrane proton fluxes in most cell types. 
Cells often express ion channels and transporters at specific locations of the 
plasma membrane to regulate ion and metabolite fluxes. For example, T-tubules in 
cardiomyocytes are important regions at the cell membrane for rapid communication 
between extracellular and cytoplasmic environments because they are highly invaginated 
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into the center of cells and contain abundant ion channels, transporters and pumps. In the 
meantime, this special morphology also separates T-tubule regions from the bulk space 
and slows the solution change between T-tubules and the bulk space [185]. Monitoring 
this solution change event can be accomplished by using fluorescent sensors attached to 
the plasma membrane of T-tubules and sarcolemma regions and will help us better 
understand how T-tubules communicate with the outside environment.  
Overall, this thesis describes the development of chemical tools that allow for 
visualization of proton fluxes specifically at the cell surface. Combined with state-of-the-
art optogenetic tools and imaging modalities, our approaches will allow for high-
throughput screening for ion channels and transporters that represent the second biggest 
group of membrane proteins as drug targets [186]. In theory, the pH sensor can be 
replaced with any ion- or metabolite- sensitive fluorescent sensor. Therefore, our 
approaches are readily adaptable to visualize most electrogenic and non-electrogenic 
transport events at the plasma membrane. Given that glycocalyces of living organisms 
can be engineered with unnatural sugars or labeled with WGA, further application and 
optimization of these approaches will allow for real-time and spatiotemporal 
measurement of ions or metabolites transport in vitro and in vivo.  
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